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ABSTRACT 
   
Title : Effectiveness of soya protein consumption on the menopausal symptoms 
among women in Samayanallur at Madurai. Objective:  To assess the level of 
menopausal symptoms among women  in control and experimental group in 
Samayanallur at Madurai, to evaluate the effectiveness of soya protein consumption on 
menopausal symptoms among   women  in Samayanallur at Madurai, to find the 
association between menopausal symptoms with selected demographic variables in 
control and experimental group in Samayanallur at Madurai.  Hypotheses : There is a 
significant difference in the level of menopausal symptoms before  and after soya 
protein consumption among women  in control and experimental  group,   there is a 
significant association between level of menopausal symptoms and selected 
demographic variable among women in control and experimental group. Conceptual 
Framework: It was based on Kenny’s outcome based theory.  Methodology :  Quasi-
experimental – Non equivalent control group design. Menopausal women were selected 
by purposive sampling technique.  This study was conducted in Samayanallur at 
Madurai. A total of 60 women were included in the study. 60grams soya bean given 
daily for 4 weeks. Results: Result showed that level of Menopausal symptoms among 
women in both groups. Experimental group post test mean was 10.6 standard deviation 
3.70, Control group post test mean was 17.07 standard deviation 3.39. Experimental 
group post test mean was less than control group post test mean. ‘t’ value was 7.05, ‘p’ 
value was 0.000. Conclusion: Menopausal women who consuming soya protein 
60grams daily  had a statistically significant in reducing the level of menopausal 
symptoms. 
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CHAPTER-I 
INTRODUCTION 
 
 “Women need to devise their own rite of passage, celebration of what 
could be regarded as the restoration of a woman to herself.” 
- German Greer 
 “On a planet where for thousands of years, even today, a woman’s worth 
has been judged exclusively by the productivity of her womb, what the hell is the 
point of a barren when?” 
        -Elissa Stein and susan 
 
 Being a woman is very special. Nature takes her through a series of transitions 
from her birth until death, which includes menarche, pregnancy, labor, motherhood 
and menopause. Each of these stages stands for different phases in her life which 
includes both physical and psychological changes. 
 
 A woman is a female human. The term woman is usually reserved for an adult. 
Women are typically capable of giving birth from puberty until menopause. Women’s 
health concerns including sex, pregnancy, birth control, menopause, weight control 
and cancer. 
 
 Countries with more gender equality have better economic growth. Companies 
with more women leaders perform better. Peace agreements that include women are 
more durable. Parliaments with more women enact more legislation on key social 
issues such as health education, anti-discrimination and child support. 
 
 International women’s day is celebrated on March 8 in every year. This year 
theme “Equality for women in progress for all” emphasizes how gender equality, 
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empowerment of women, women’s full enjoyment of human rights and the 
eradication of poverty are essential to economic and social development. 
 
The women life has three phases. The first stage is called virginity or 
maidenhood. The second stage is motherhood when consciousness turns outward, to 
the home and family. The final stage which begins at menopause is called the crone or 
wise women stage. 
 
Menopause is seen more as a gateway to a second adulthood. Menopause is 
the permanent cessation of ovarian function. The term was originally coined to 
describe this reproductive age in human females, where there is an end for fertility, 
traditionally indicated by permanent stopping of monthly menstruation or “menses”. 
 The word "menopause" literally means the "end of monthly cycles" from the Greek 
words pausis (cessation) and the word root men (month) 
 
Menopause doesn't creep up on women and hit them all of a sudden. There are 
Three distinct stages to menopause; Premenopausal, Perimenopause and 
PostMenopause. Premenopause is the word used to describe the years leading up to 
lastperiod, when the levels of reproductive hormones are already becoming 
lower.Perimenopause is defined as the period immediately prior to menopause and the 
firstYear after menopause and Post menopause is the period after the final 
menstrualPeriod. Climacteric is the phase of aging process during which a woman 
passes from the reproductive to the non-reproductive stage. This phase4 covers 5-10 
years on each side of menopause, premenopause and post menopause. (Alan 
H.DeCherney).        
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 Menopause is a natural phenomenon, but then it causes many symptoms which 
Deteriorates the health of the women and makes her in trouble for the increased 
chance of many complications. In the menopausal years, many women undergo 
noticeable and clinically observable physical changes resulting from hormonal 
fluctuations.  
 
 Signs and effects of the menopause transition can begin as early as age 40, 
although most women become aware of the transition in their mid to late 40s, often 
many years after the actual beginning of the perimenopausal window. The typical age 
range of menopause is between ages of 40 and 60 and the average for last period is 51 
years in western countries. In some developing countries, the median age for natural 
menopause is at 44 years. In India as per the 2007 reports, the mean age at menopause 
ranges from 40 to 50 years. 
 
 Age at which menopause occurs is genetically predetermined. The age of 
menopause is not related to age at late pregnancy. It is also not related to number of 
pregnancy, lactation, use of oral pill,  socio economic condition, race, height or 
weight, thinner women have early menopause. Severe malnutrition may cause early 
menopause. The age of menopause ranges between 45-55years, average being 50 
years. (D.C. Dutta). 
 
Menopause is a significant event in most women’s lives as it marks the end of 
a woman’s natural reproductive life. The perimenopausal and early postmenopausal 
period is typically characterized by falling levels of endogenous oestrogen, which can 
give rise to vasomotor symptoms that are severe and disruptive, particularly in the 
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perimenopausal and early postmenopausal years. These vasomotor symptoms include 
hot flushes (also known as ‘hot flashes’), sweating and sleep disturbances. 
Hot flushes are described as the sudden feeling of heat in the face, neck and 
chest (WHO 1996). Hot flushes are frequently accompanied by skin flushing and 
perspiration followed by a chill as core body temperature drops (Freedman 
2001;Kronenberg 1990).The flushes vary in frequency, duration and severity and may 
be spontaneous and unpredictable (Freedman 1995).Hot flushes that occur during the 
night are typically referred to as night sweats. Flushes and night sweats are of concern 
in themselves because they can disrupt sleep patterns and alter daily activities, which 
can then lead to fatigue and decreased quality of life (NAMS 2004). Hot flushes are 
thought to result from both the brain’s response to diminished hormones and the 
hormonal fluctuations that occur during the menopausal transition, which then leads 
to instability of thermoregulatory mechanisms (that regulate temperature) inthe 
hypothalamus (Freedman 2001; Kronenberg 1987). 
 
 The initial years of menopause are often accompanied by vasomotor 
symptoms such as hot flashes and night sweats, somatic symptoms such as fatigue, 
body aches, and vaginal dryness, and psychological symptoms such as irritability, 
anxiety, depression, decreased libido, and difficulty sleeping. These symptoms can 
begin during the menopausal transition up to 2 years before the cessation of menses.  
 
           World Menopause Day is celebrated on 18th October every year. World 
Menopause Day started all the way back in 1984 and was instituted by the 
International Menopause Society and the World Health Organization (WHO). The 
Menopause day is devoted to creating awareness about one of the most difficult time 
in a women’s life. 
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  Many pharmacological and nonpharmacological measures are being used by 
perimenopausal women for centuries to overcome these devastating symptoms. Soya 
bean one such agent used by perimenopausal women is (glycine max) a leguminous 
plant containing 40% protein, minerals (like calcium, iron, phosphorus, and zinc), 
vitamins (like B complex, vitamin E) and phytoestrogen and lecithin. FDA(Food and 
Drug Administration) has recommended adding 45 to 100 mg of soya diet in a day is 
beneficial to alleviate menopausal symptoms. 
 
  Soya beans are very rich in nutritive components. Besides the very high 
protein content. It contains a lot of fiber and is rich in calcium, magnesium. 100g soya 
bean contains 36.5gm of protein and 200 mg of is flavones. 60gm soya bean contains 
21.9 gm. Daily recommended protein for women and is 46gm per day. Green 
soybeans are called Edam me. It is sweet taste. According to an article published in a 
2007 edition of the “Journal of the International Society of sports Nutrition” 
physically active women require protein 1.4 to 2.0 gram per kilogram of body weight. 
According to the Institute of medicine 0.8gram of protein per kilogram of body 
weight.  
 
It is high in phytoestrogen which is a plant chemical that acts like estrogen 
which is produced naturally in the body.  These plant estrogens are thousands of times 
weaker than natural estrogen. But they also circulate in the blood at levels thousands 
of times higher than natural estrogen. Soya bean contains Genistein, one of the 
phytochemicals. It blocks cancer development by preventing tumors from creating 
blood vessels that would provide nourishment for growth. One serving a day (1cup of 
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soya bean) has shown to be effective for cancer prevention. It contains synthetic 
estrogen to protect women from bone weakness and maintain a healthy heart.  
For many women menopause has been a worrying and difficult time of life. 
She needs to be conscious of her own self-worth, strength, and wisdom. It is the Rites 
of Passage were women should go for natural remedies. 
 
1.1 NEED FOR THE STUDY 
 “From birth to age 18 a girls need good parents, from18 to 35 she needs 
good looks, from 35 to 55 she needs a good personality, and from 55 on she needs 
good cash.” 
- Sophia Tucker 
“Women don’t realize how powerful they are” 
- Judith light 
 
             Women experience various turning points in their life cycle, which may be 
developmental or transitional. Midlife is one such transitional period which brings 
about important changes in women. Menopause is a unique stage of female 
reproductive life cycle, a transition from reproductive to non reproductive stage.  
 
Menopause is said to be a universal reproductive phenomenon, which can be 
perceived as unpleasant. This period is generally associated with unavoidable 
manifestation of aging process in women. Menopause may be smooth experience for 
some women with only symptom of cessation of menstrual flow while others face one 
or more of post menopausal symptom. In present era with increased life expectancy, 
women are likely to face long periods of menopause accounting to approximately a 
third of her life. 
 
            In the developed world, mean life expectancy for women since 1990 has 
increased from 50 to 81 years. The life expectancy of the population around the world 
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is estimated to be 75-80 years. Today, there are over 200 million postmenopausal 
women worldwide and 40 million in India. According to the World Health 
Organizationthey estimated that by 2025 there will be 1.1 billion women above the 
age of 50 years experiencing menopause and the average age of experiencing the 
symptoms of menopause is 47.5years. 
 
             According to Indian Menopause Society Researchthere are about 65 million 
Indian women over the age of 45 and estimated that in the year 2026, the population 
in India will be 1.4 billion, people over 60 years will be 173 million and the 
menopausal population will be  103 million. The average age of Indian menopausal 
women is 47.5 years.  
 
A study was conducted to establish the age at onset of menopause and the 
prevalence of menopause and menopausal symptoms in South Indian women. 352 
postmenopausal women attending the outpatient clinics of obstetrics and gynecology 
department of Dr TMA Pai Hospital, a tertiary care Hospital in South India, were 
included in the study. The Menopause-Specific Quality of Life (MENQOL) 
questionnaire was used for analysis and data were presented as percentages for 
qualitative variable. The study results revealed that the mean age at menopause was 
48.7 years. Most frequent menopausal symptoms were aching in muscle and joints, 
feeling tired, poor memory, lower backache and difficulty in sleeping. The vasomotor 
and sexual domains were less frequently complained when compared to physical and 
psychological domains. The study concluded that the age at onset of menopause in 
southern Karnataka (India) is 48.7 years which is four years more than the 
mean menopause age for Indian women.  
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 Menopause is natural process, almost all women during and after the 
menopause suffers from typical symptoms with approximately 40%seeking a medical 
help for various symptoms like vasomotor, psychological, urogenital, musculoskeletal 
symptoms. Recent studies failed to show the protective effect of hormone replacement 
therapy in reducing the risk of coronary artery disease and have revealed an increased 
risk of heart disease, stroke and invasive breast cancer. So there is need of natural 
approaches to relieve menopausal discomfort and soya is considered as “super food” 
for relieving menopausal symptoms. 
 
Soya bean is commonly called wonder bean since it is an excellent source of 
nutrients such as proteins, fats, carbohydrates, vitamins and minerals.  It contains     
43gm of protein per 100 gm of soya which is the highest among the pulses. It also 
contains 19.5gm of fat, 21gm of carbohydrate and provides 432 kcal per 100gm.Soya 
bean also contains a family of chemical compounds called phytoestrogens. 
Phytoestrogens have chemical structures similar to the estrogens produced in the body 
and it is believed that eating foods rich in phytoestrogens can help alleviate low 
estrogen production in the body. Isoflavones arise the active ingredients in soya beans 
which have estrogen-like properties. Isoflavones reduces menopausal symptoms, 
blood cholesterol level, incidence of cancer and osteoporosis. Eating 100gm of soya 
protein per day provides 200 mg of soya isoflavones. A target range of 80-160 mg of 
isoflavones per day is needed for adequate relief of menopausal symptoms. Soya bean 
is used extensively as human food, animal feed and for industrial purposes. All the 
products of soya bean are of dietary importance such as soya bean cheese, soya bean 
milk, soya bean oil, soya bean meal. 
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Some types of soya protein content foods are yellow split peas, black turtle 
bean, Red Kidney beans, Red lentils, soya beans, sesame seeds, sunflower seeds, 
pumpkin seeds, and broccoli parsley, Raspberries, Apple, Pears and Plums. Some 
complementary therapies are available. Such as yoga programmed Acupuncture, 
Acupressure, Hypnotherapy, Aromatherapy, Reflexology and homeotherapy. Many 
women like the use of herbal remedies as a more natural way of managing their 
menopausal symptoms than conventional medicines. Some herbs may have estrogenic 
properties. Its phytoestrogens (Isoflavones) are naturally occurring, for relief of 
menopausal symptoms. Oestrogen like compounds derived from plants for more than 
20 years. Isoflavones are found in beans and pulses particularly soya beans and soya 
products. So I provided the Red color Kidney shaped bean. 100 gram Red Kidney 
beans with salt, cooked and boiled beans nutritional value is 225 calories, fat 
0.88gram, carbohydrate 40.36gram, protein 15.35gram, calcium 5%, iron 29%, and 
vitamin c 4%. (Ralph). 
 
Atmaca  (2008) conducted  a double randomized study in tertiary care centre 
united states to assess the effect of soya protein containing isoflavones on quality of 
life in post menopausal women. A sample of 93 healthy, ambulatory women were 
randomly assigned to receive 20 gm of soya protein containing 160 mg of isoflavones 
versus matched placebo (20gm whole protein milk) and quality of life was assessed 
by menopause-specific quality of life questionnaire.  The study results revealed that 
there was a significant improvement in all 4 quality of life scales (vasomotor, 
psychosexual, physical and sexual) among the women taking soya protein and no 
changes were seen in placebo, the study concluded that use of soya isoflavones as an 
alternative to estrogen therapy may be potentially safeful and seeming safe in women 
who are looking for relief from menopausal symptoms. 
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Soya also helps to promote better health and has gain health benefits in 
preventing metabolic disorders, cancer and cardiovascular conditions. This motivated 
the investigator to assess the effect of soya protein on menopausal symptoms. 
 
1.2 STATEMENT OF THE PROBLEM 
     “A study to assess the effectiveness of soya protein consumption on the 
menopausal    Symptoms among women inSamayanallur at Madurai.” 
 
1.3 OBJECTIVES OF THE STUDY 
1. To assess  level menopausal symptoms among women in control and 
experimental group in Samayanallur at Madurai. 
2. To evaluate the effectiveness of soya protein consumption on menopausal 
symptoms among   women  inSamayanallur at Madurai.  
3. To find the association between menopausal symptoms with selected 
demographic variables in control and experimental group in Samayanallur at 
Madurai.   
 
1.4 HYPOTHESES 
H1:  There is a significant difference in the level of menopausal symptoms before 
and after soya protein consumption among women  incontrol and 
experimental  group. 
H2:  There is a significant association between level of menopausal symptoms 
and selecteddemographic variable among womenincontrol and experimental  
group. 
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1.5 OPERATIONAL DEFINITIONS   
Effectiveness  
In this study effectiveness refers to outcome of soya protein consumption on 
reducing the menopausal symptoms among women as measured by Menopausal 
Rating Scale developed by Heinemann (2003). 
 
Soya protein   
In this study it refers to soya protein is one of the plant protein. It contains 
genistein and isoflavones. It acts like estrogen which is produced naturally in the 
body. These plant estrogens are thousands of time higher than natural estrogen. It 
helps to reduce the menopausal symptoms. 60gm cooked soyabean given daily for 
4weeks. 
 
Menopausal symptoms 
 In this study it refers to  symptoms associated with menopause  (hot flashes, 
heart discomfort, sleep problems, depressive mood, irritability, anxiety, physical and 
mental exhaustion, sexual problems, bladder problems, dryness of vagina, joint and 
muscular discomfort) as listed in Menopausal Rating Scale developed by Heinemann 
(2003). 
 
Women 
 In this study it refers to women who were in the age group of 45-56 years in 
Samayanallur at Madurai. 
 
1.6 ASSUMPTIONS 
The study assumes that 
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 women  will suffer from menopausal symptoms. 
 women are not aware that soya protein will reduce the menopausal symptoms 
 reduction of menopausal symptoms may improve the quality of life of 
menopausal women. 
 
1.7 DELIMITATION 
1. The study is limited to menopausal women of Samayanallur only 
2. This study is limited to 4 weeks only. 
 
1.8 PROJECTED OUT COME: 
The results of the study will give strong evidence that soya protein 
consumption will reduce the menopausal symptoms among the women.  This type of 
non-invasive alternative and complementary therapy will be useful for the 
menopausal women to reduce the menopausal symptom. Hence this study will 
motivate the health care professionals to implement this soya protein consumption. 
 
 
 
 
 
 
 
 
 
 
 
  
 
Review of Literature 
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CHAPTER - II 
REVIEW OF LITERATURE 
 
Review of literature involves systematic identification, location, scrutiny and 
summary of written materials that contain information on research problem. The 
literature review is based on an extensive survey of books, journals and international 
nursing index. Research and non-research literature were reviewed to broaden the 
understanding and gain insight into the problem under study. 
 
The literature relevant to this study was reviewed and arranged in the following 
1. Literature related to Menopause. 
2. Literature related to soya protein consumption. 
3. Literature related to effect of soya protein consumption on menopausal 
symptoms. 
 
1. LITERATURE RELATED TO MENOPAUSE 
Most women can expect to live into their ninth decade with changes that 
accompany aging. Especially those associated with the menopause can be a source of 
anxiety. Menopause is a natural event in the course of every woman’s life it is a time 
of last period but symptoms can begin several years before that these symptoms can 
last for months or years. Sometimes around 40 years, the women notice that her 
menstruation is different in its duration, frequency and amount of bleeding. Changing 
levels of estrogen and progesterone which are the two female hormone produced in 
the ovaries, might lead to these symptoms (National Institute of Aging, 2006). 
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 According to North American Menopause Society (2000), the average age 
for the onset of perimenopause is 47.5 years and natural menopause occurs at the age 
of 51.4 years in western women. In rural North India, Singh and Arora (2005) found 
that the average age at menopause is 44.1 years. There were many studies reported the 
mean age of menopause between 45 to 55 years. Quazi (2006) reported it as 50 years. 
Dhillon Singh, Hamid and Mahmood (2001) document it as 49.4 + 3.4 years. Chim, 
Tan, Ang, Chew, Chowg and saw (2002), in their study mentioned as average range 
of 40 to 59 years with the mean of 49 years. 
 
Marcio L. Griebeler. (2010), conducted a cross sectional study in China to 
investigate the factors associated with hot flashes in perimenopausal (N= 817), and 
postmenopausal (N=582) women 40-60 years old. Among postmenopausal women, 
an omnivorous diet decreased the prevalence of hot flashes OR=0.38; 95% CI=0.07-
0.85. 
 
C.Nagata, (2010)   conducted a study  to evaluate the cross-sectional 
relationships of diet and other lifestyle variables to menopause. A total of 4186 female 
residents aged 45-55 in Takayama City, Japan, responded to a self-administered 
questionnaire (the response rate was 89.3%). Diet in the past year was assessed by 
semi quantitative food frequency questionnaire. Using the logistic regression model, 
associations between study variables and menopausal status were estimated in terms 
of odds ratio (OR). The study result shows that Nulliparity and lower relative weight 
were significantly associated with menopause after controlling for age (P < 0.05). The 
association of smoking with menopause was marginally significant after controlling 
for age (P =0.06). Higher intakes of fat, cholesterol, and coffee were inversely and 
significantly associated with later menopause after controlling for age, total energy, 
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parity, menarche age, and relative weight (ORs for the highest tertiles of fat, 
cholesterol and coffee intakes were 0.78, 0.79, and 0.70, respectively, P < 0.05). The 
highest tertiles of calcium and soy product intakes were significantly associated with 
menopause after controlling for the covariates (ORs = 1.25 and 1.42, respectively, P < 
0.05).The study concluded that dietary factors appear to be associated with onset of 
menopause. 
 
ShalinYadega, (2009) conducted a cross sectional study on 500 
postmenopausal women from rural areas attending OBG clinic at Government 
Medical College, Jammu India. This study showed that the mean age of menopause 
was 49.35 years and the predominant symptoms were fatigue and lack of energy 70%, 
rheumatology related symptoms 60%, Cold sweats, Weight gain, Irritability and 
nervousness 50%.Dyslipidemia was seen in 39% and metabolic syndrome in 13%. In 
this study group 10% had a hectic lifestyle, 55% sedentary and 35% had moderate 
lifestyle. Only 5% of women received Hormonal Replacement therapy. Among these 
women 2.4% were hypertensive, 9% diabetic and 8% of them had dyslipidemia. The 
study concluded that there is an alarmingly high prevalence of cardiovascular risk 
factors especially diabetes, hypertension, dyslipidemia and obesity in postmenopausal 
women from rural areas. 
 
Jones G L, Sutton A (2009)conducted  a study to assess the quality of life in 
obese postmenopausal women. The aim of this review was to identify the ways in 
which obesity affects the health-related quality of life of postmenopausal women. 
This was considered important because a growing body of literature has identified 
obesity as a significant predictor for a poor psychological wellbeing and negative 
HRQoL, particularly in women, and because during the transition through the 
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menopause women tend to accumulate more body weight. After searching eight 
electronic databases, only nine papers appeared meaningful. Although a meta-analysis 
was not possible, we found that a body mass index >30 kg/m2 was associated with a 
poor HRQoL in postmenopausal women; particularly in the areas associated with 
physical functioning, energy and vitality, and health perceptions. Thus, clinical 
management of obese postmenopausal women should focus on weight reduction and 
exercise in an attempt to improve wellbeing in these areas. 
 
Kevan Richard (2009) conducted a study to assess the quality of sexual life 
and menopause. The importance of female sexual fulfillment is increasingly 
recognized in today's society. Women's sexual lives continue well into the 
menopausal years and beyond; however, the impact of menopause on the quality of 
that sexual life has not been comprehensively studied in the medical literature. This 
review attempts to clarify the impact of the physiological, psychological and 
psychosocial changes occurring at midlife that may affect women's quality of sexual 
life. Pharmaceutical and psychological interventions that may assist in improving the 
quality of sexual life of menopausal women are discussed. Contrary to popular 
expectation, there is a substantial prevalence of sexual activity among middle-aged 
women, and the majority of middle-aged women express satisfaction with the quality 
of their sexual lives. 
 
Avis N E, Colvin (2009) did a study to assess the changes in health related 
quality of life during the time of menopausal transition. The study was done with the 
sample of 3302 who were between the age group of 42 to 52 years. The findings of 
the study revealed the little impact of menopausal transition on health related quality 
of life. 
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Suzanne (2009) published a study on postmenopausal women’s loss of sexual 
desire effects health, quality of life. The study was done through telephone interview 
with 1189 postmenopausal women by using quality of life surveys. The study result 
shown between 9% and 26% of women suffer with the loss of sexual desire and it is 
mainly depends on the age and the menopausal stage. 
 
Amanda J Welton (2008) conducted a cross sectional  study among 
postmenopausal women aged 50 to 69 to assess the effect of combined hormone 
replacement therapy (HRT) on health related quality of life. Health related quality of 
life and psychological wellbeing as measured by the women’s health questionnaire. 
After one year small but significant improvements were observed in three of nine 
components of the women’s health questionnaire for those taking combined HRT 
compared with those taking placebo. Hot flushes were experienced in the combined 
HRT and placebo groups by 30% and 29% at trial entry and 9% and 25% at one year, 
respectively. No significant differences in other menopausal symptoms, depression, or 
overall quality of life were observed at one year. Combined HRT started many years 
after the menopause can improve health related quality of life. 
 
Mary C, Mark D (2008) has conducted a cross sectional study to assess the 
quality of life and related factors to impairment of quality of life among 
postmenopausal women. Cluster sampling technique was used and the data was 
collected from 480 postmenopausal women by using MENQOL scale. The study 
revealed that the menopause causes poor quality of life which is dependent to the 
work of the women and socio demographic variables. 
 
Mahadeen A.I. (2008) did a study to describe the perceptions of Jordanian 
midlife women about making the menopausal transition. Audio taped interviews were 
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conducted with 25 peri-menopausal Jordanian women. Interviews were analyzed as 
appropriate for descriptive qualitative inquiry. The major theme generated was ‘A 
Life Transition’, which included: a time of no more reproductive obligations, 
changing from the burdens and obligations of reproductive roles and responsibilities 
to freedom, relief and rest; a time for managing peri-menopausal symptoms; and a 
time for growing into a wise woman and accepting aging as a part of life. 
 
Young, Rabago, (2007) objectively measured the sleep quality among 589 
premenopausal, perimenopausal, postmenopausal women. Sleep quality was 
measured by polysomnography and self reported sleep problems. Results revealed 
that the quality of sleep was not worse in perimenopausal compared with 
premenopausal women. 
 
Jeremy (2007) done a study to determine the age of attaining menopause 
among Indian women and they found that 3.1 percent about 17 million of Indian 
women are attaining menopause between the ages of 30 and 34, 8 percent are in the 
age of 39 and 19 percent have attained in the age of 41 years. Medical experts say that 
natural menopause occurs in between the ages of 45 and 55 and the mean age is 51. 
 
Sharma S. (2007) conducted a cross-sectional study on perceptions regarding 
menopause, prevalence of menopausal symptoms and association of family 
environmental factors with menopausal symptoms among 100 postmenopausal and 
100 perimenopausal rural women in south India.57% of postmenopausal women 
perceived menopause as convenient. The study findings revealed that 69% of them 
complained of diminishing abilities after menopause 23% felt that sexual life ends 
with the onset of menopause, 16% reported that their husbands had become 
disinterested in them after menopause and 11% were apprehensive about the loss of 
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femininity. A higher proportion of menopausal women reported hot flushes, night 
sweats, urge incontinence and other somatic symptoms. They concluded that there 
was significant associations between multiple somatic symptoms, vasomotor 
symptoms, urge incontinence, loss of sexual desire, and menopause. 
 
Tandon.RV. (2007) conducted a cross-sectional study on factors associated 
with menopausal symptoms and their relationship with the quality of life. Data was 
collected from 886 women of mean age 48.62 years with a questionnaire including 
demographic variables, quality of life and menopause symptom checklist. The study 
revealed statistically significant variables like health problems, recent life stresses, 
absence of relaxation methods, number of pregnancies, inadequate and unbalanced 
nutrition, age and dissatisfaction in marriage. There was negative relation between 
menopausal symptom scores and quality of life scores. Study recommended that stress 
management and health-promoting practices should be incorporated into menopausal 
care programmes to improve health and quality of life of middle aged women. 
 
Kakkar V, Kaur D et al. (2007)  conducted a cohort study to find out the 
variation in menopausal symptoms with age, education and working/non working 
status in North-Indian sub population. The MRS scale, a self administered 
standardized questionnaire was applied with additional patients related information 
for analysis. The results were evaluated for psychological, somatic and urogenital 
symptoms. Average age at which menopause set in the cohort was found to be 48.7± 
2.3yrs.The cohort was divided into peri (35-45) menopausal, early menopause (46-51) 
and the postmenopausal (52-65). A significantly higher % of perimenopause women 
(36%) showed a psychological score ≥ 7 while a higher % of postmenopausal women 
showed somatic score and urogenital score ≥ 7. Working women suffer more from 
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psychological symptoms whereas nonworking women showed a greater incidence of 
somatic symptoms. Educated women showed a lower incidence of psychological and 
somatic symptoms. Thus, the study concludes that age; level of education and 
working/non working status may also contribute to significant variation of 
menopausal symptoms. 
 
Peter Chedrauiab (2006)  evaluated the quality of life and determined the 
factors related to its impairment among postmenopausal Ecuadorian women. 
Postmenopausal women that participated in a metabolic syndrome screening and 
educational program at the Institute of Biomedicine of the Universidad Católica of 
Guayaquil, Ecuador were interviewed using the Menopause-Specific Quality of Life 
Questionnaire. Mean domain scores as well as factors associated to higher scores 
within each of the domains of the questionnaire (vasomotor, psycho-social, physical 
and sexual) were determined. Three hundred twenty-five postmenopausal women 
were surveyed. More than 50% of women had scores above the median for each 
domain of the questionnaire. In this postmenopausal Ecuadorian population, 
impairment of quality of life was found to be associated to age and related conditions 
such as abdominal obesity, hypertension and hyperglycemia. 
 
 Chaudary (2005) conducted a study in Ahmedabad on postmenopausal 
women for evaluation of osteoporosis. Average age of menopause was 46.7 years and 
women were +4 years (those who passed menopause 4 years back). Results showed 
severe osteoporosis were found in women from age 60 and above, most of them with 
moderate osteoporosis and majority required surgical treatment with added risk of 
surgery and anesthesia. 
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 According to Jog (2005) conducted a study to assess the  Bone Mineral 
Density (BMD) of women in post-menopausal age. Early detection of osteopenia and 
osteoporosis and its appropriate management was dealt in the study. Measurement of 
BMD was done in postmenopausal women (min. 2 years). Appropriate advice 
regarding diet,exercises and medication was give in depending upon T-score and Z-
score. Follow up BMD was done every year for 3 years. It was found that osteopenia 
responds better than they proved that Osteoporosis shows slow improvement and 
regular exercise gives early results. 
 
Young kin & Davis, (2004) conducteda studyto compare the non-
pharmacological measures for the menopausal symptoms. Such as avoidance of 
caffeine, smoking, wearing cotton clothes is the measures for hot flushes. Exercising 
regularly in the morning or early evening, doing quiet activity just before the bedtime, 
sleeping in a comfortable environment, avoidance of sleeping medications, limited 
food intake prior to sleep are the measures for sleep problems and night sweats. 
Consuming calcium contained food items to minimize the joint and back discomforts. 
Stress reduction techniques are helpful for the psychological problems. Seeking 
medical help are for the sexual and urinary problems. They concluded that these the 
non-pharmacological measures are useful.  
 
 Smith, (2002) reported that immediate changes of menopause are hot flushes 
in the chest, face, neck and back, insomnia, mild to moderate depression, bone, joint, 
muscle aches, swelling, heart beat fluctuations, headache, vagina dryness and 
increased swelling.  
 
Chim H, Tan BH et al, (2002) conducted a  population based survey with  a 
representative sample of 495 Singaporean migrant women aged 40 to 60 to determine 
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the prevalence of 17 menopausal symptoms. The mean age of participants was 49 
years and the classical menopausal symptoms found were hot flushes (17.6%), 
vaginal dryness (20.7%) and night sweats (8.9%). The most prevalent symptom 
reported was low backache with aching muscle joints (51.4%). The most well-known 
effect of these is the "hot flash" or "hot flush", a sudden temporary increase in body 
temperature. They found that the  symptoms were reported due to hormonal changes 
underlying menopause, which are caused by aging, other health states, psychosocial 
factors and life style. 
 
2. LITERATURE RELATED TO SOYA PROTEIN CONSUMPTION 
J.Lissa, (2011) conducted a randomized cross-over clinical trial to determine 
the effects of soya bean consumption on markers of inflammation and endothelial 
function in postmenopausal women with the metabolic syndrome. This study included 
postmenopausal women with the metabolic syndrome. Participants were randomly 
assigned to consume a control diet (Dietary Approaches to Stop Hypertension 
[DASH]), soya protein diet, or soya nut diet, each for 8 weeks. Red meat in the DASH 
diet (one serving/day) was replaced by soy protein in the soya protein diet and by 
soya nut in the soya nut diet. The results for nitric oxide levels, the difference from 
the control diet was 9.8% (P < 0.01) on the soya nut and −1.7% (P = 0.10) on the soy 
protein diets. The difference from the control diet for serum E-selectin was −11.4% 
(P<0.01) on the soya nut consumption and −4.7% (P = 0.19) on the soya protein diet. 
Soya nut consumption reduced interleukin-18 compared with the control diet 
(difference from the control diet: −9.2%, P < 0.01), but soya protein did not 
(difference from the control diet: −4.6%, P=0.14). For C-reactive protein, the 
difference from the control diet was −8.9% (P < 0.01) on the soya nut diet and −1.6% 
(P < 0.01) on the soya protein diet. The results revealed that Short-term soya nut 
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consumption reduced  some markers of inflammation and increased plasma nitric 
oxide levels in postmenopausal women with the metabolic syndrome.  
 
Silvina Levis, (2010)  conducted a  prospective clinical 6 week trial study was 
conducted in Australia enrolled 25 postmenopausal women who received a diet 
supplemented with soy flour, red clover sprouts or linseed each for 2 week in turn. 
Vaginal maturation value is increased after the 2 week soy rich diet (P< 0.05) but not 
after red clover or linseed. 
 
Sharon R. Akabas, (2010) conducteda  prospective clinical trials study  in a 
United States 19 postmenopausal women 45-65 years old were randomized to soya 
foods, substituting one-third of their caloric intake, or usual diet for 4 week. One main 
dish made from whole soy beans or texturized vegetables soy protein was supplied by 
the study to provide a daily intake of 165mg of conjugated isoflavones. Compliance 
with the soya diet was 73%. In 68% of the women consuming soya foods, the 
percentage of superficial cells, an indication of the control group, did not change; it 
increased in 19% and decreased in 13%. Among the women in the control group, 71% 
showed no change, 8% had an increase, and 21% had a decrease. These differences 
were not significant. 
 
Marica L Griebeler (2010) conducted a clinical trial study  in Canada, 99 
women aged 45-60years and menopausal for 1-8 year were enrolled in a 16 week 
study of quality of life and hot flash frequency and severity. They received 1 muffin 
daily containing soy, wheat, or flaxseed flour. Soya muffins contained 25 gram of 
soya flour, supplying 42 mg of isoflavones daily. Among the 87 women who 
completed the trial, there was no significant difference in the frequency and severity 
of hot flashes between treatment groups. 
24 
 
Shu XO, Zheng Y et al, (2009) conducteda case cohort study  to assess the 
association of soy food intake after diagnosis of breast cancer with mortality and 
cancer recurrence among 5042 female breast cancer survivors in china. Women aged 
20 to 75years with diagnoses between March 2002 and April 2006 were recruited and 
followed up through june 2009. Information on cancer diagnosis and treatment, life 
style exposures after cancer Diagnosis and disease progression was collected at 
approximately 6 months after cancer diagnosis and was reassessed at 3 follow-up 
interviews conducted at 18, 36, and 60 months after diagnosis. Annual record linkage 
with the Shanghai Vital Statistics Registry database was carried out to obtain survival 
information for participants who were lost to follow-up. Medical charts were 
reviewed to verify disease and treatment and total mortality and breast cancer 
recurrence or breast cancer–related deaths. Cox regression analysis was carried out 
with adjustment for known clinical predictors and other lifestyle factors. Soy food 
intake was treated as a time-dependent variable. The study results revealed that during 
the median follow-up of 3.9 years (range, 0.5-6.2 years), 444 deaths and 534 
recurrences or breast cancer–related deaths were documented in 5033 surgically 
treated breast cancer patients. Soya  food intake, as measured by either soy protein or 
soya isoflavone intake was inversely associated with mortality and recurrence. The 
hazard ratio associated with the highest quartile of soy protein intake was 0.71 (95% 
confidence interval [CI], 0.54-0.92) for total mortality and 0.68 (95% CI, 0.54-0.87) 
for recurrence compared with the lowest quartile of intake. The multivariate-adjusted 
4-year mortality rates were 10.3% and 7.4%, and the 4-year recurrence rates were 
11.2% and 8.0%, respectively, for women in the lowest and highest quartiles of soy 
protein intake. The inverse association was evident among women with either 
estrogen receptor–positive or –negative breast cancer and was present in both users 
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and nonusers of tamoxifen. The study concluded that, soya food consumption was 
significantly associated with decreased risk of death and recurrence among women 
with breast cancer. 
 
Sun J (2006)  conducted a clinical trial study to determine the efficacy of a 
morning/evening menopause formula (morning capsule contains panax ginseng, black 
cohosh, soya  and green tea extracts; evening capsule contains black cohosh, soya, 
kava, hops, and valerian extracts) for relieving menopausal symptoms such as hot 
flashes and sleep disturbance.Healthy postmenopausal women, between 45 and 65 
years of age, were asked to take the menopause formula orally, one capsule of the 
morning formula every morning and one capsule of the evening formula every 
evening for 2 months. The Greene Climacteric Scale (GCS) and the Pittsburgh Sleep 
Quality Index (PSQI) were used to determine the efficacy. Morning/evening 
menopause formula significantly reduced the number of hot flashes. The reduction in 
the number of hot flashes was observed as early as at the end of the second week. At 
the end of the second week, the number of hot flashes was reduced by 47%. The 
morning/evening menopause formula also significantly reduced the GCS total and 
subscale scores. At the end of the eighth week, the vasomotor, anxiety, and depression 
scores of GCS were reduced by 50%, 56%, and 32%, respectively. Furthermore, the 
morning/evening menopause formula significantly reduced global PSQI score and 
scores in five components (sleep quality, sleep latency, sleep duration, sleep 
disturbance, and daytime dysfunction) by 18%-46%. This study suggests that the 
morning/evening menopausal formula is safe and effective for relieving menopausal 
symptoms including hot flashes and sleep disturbance. 
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Jang He. (2005) conducted a randomized, double-blind, controlled trial was 
conducted on  China to examine the effect of soya protein supplementation on blood 
pressure in persons with pre hypertension or stage hypertension. 302 participants 35 
to 64 years of age with an initial untreated systolic blood pressure of 130 to 159 mm 
Hg, diastolic blood pressure of 80 to 99 mm Hg, or both were randomly assigned to 
receive 40 gm of isolated soya  protein supplements per day or complex carbohydrate 
control for 12 weeks. Blood pressure measurements were obtained by using random-
zero sphygmomanometers at baseline at 6 and12 weeks. The study result revealed at 
baseline, the mean systolic and diastolic blood pressures were 135.0 mm Hg (SD 
10.9) and 84.7 mm Hg (SD 6.9), respectively. Compared with the control group, the 
net changes in systolic blood pressure and diastolic blood pressure were -4.31mm Hg 
(95% CI, -2.11 to -6.51 mm Hg; P < 0.001) and -2.76mm Hg (CI, -1.35 to -4.16 mm 
Hg; P < 0.001), respectively, after the 12-week intervention. The net changes in 
systolic and diastolic blood pressure reductions were -7.88 mm Hg (CI, -4.66to -11.1 
mm Hg) and -5.27 mm Hg (CI, -3.05 to -7.49 mmHg), respectively, in persons with 
hypertension and -2.34 mmHg(CI, 0.48 to -5.17 mm Hg) and -1.28 mm Hg (CI, 0.52 
to -3.07mm Hg), respectively, in those without hypertension. The study concluded 
that Soya bean protein supplementation resulted in a reduction in systolic and 
diastolic blood pressure and increased intake of soya protein may play an important 
role in preventing and treating hypertension. 
 
Xianglan Zhang, Xiao ouShu et al, (2003) conducted a population-based 
prospective cohort study of 75,000 Chinese women aged 40–70 years a baseline 
survey was conducted from 1997 to 2000 in Japan to examine the relationship 
between soya food intake and incidence of coronary heart disease (CHD). Participants 
included in this study were 64,915 women without previously diagnosed CHD, stroke, 
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cancer and diabetes at baseline. Information on usual intake of soya foods was 
obtained at baseline through an in-person interview using a validated food-frequency 
questionnaire. Cohort members were followed biannually through in-person 
interviews. After a mean of 2.5 yrs (162,277 person years) of follow-up, 62 incident 
cases of CHD (43 nonfatal myocardial infarctions and19 CHD deaths) were 
documented. There was a clear monotonic dose-response relationship between soya 
food intake and risk of total CHD (P for trend = 0.003) with an adjusted relative risk 
(RR) of 0.25 (95% CI, 0.10–0.63) observed for women in the highest vs. the lowest 
quartile of total soy protein intake. The inverse association was more pronounced for 
nonfatal myocardial infarction (RR = 0.14; 95% CI, 0.04–0.48for the highest vs. the 
lowest quartile of intake; P for  trend =0.001). This study provides, for the first time 
direct evidence that soy food consumption may reduce the risk of CHD in women. 
 
ArezooHaghighianRoudsari, (2003), conducteda clinical trial study  before 
and after type was carried out on 15 postmenopausal women 45-64 years of age. 
Women were given 35 gram soya protein per day for 12 weeks. Information on 
weight, height, body mass index, two 24 hour food consumption recall and physical 
activity were collected at the start, 6 and 12 weeks of the study. Soya protein at 35 g 
level containing 93.3mg Isoflavones were given to women daily. Women were 
provided with a special cup for measuring soya. Cooking instructions were also given 
to the women. Soya protein consumption resulted in a significant reduction in the 
urinary deoxypyridinoline and increasing of total alkaline phosphatase (P<.05), 
although the alterations in osteocalcin, c-telopeptide and type I collagen telopeptide 
were not significant. Mean age was 52.9± 4.3 years, yearspostmenopause 5.47±3.4 
years and mean height 157.4±7.2 centimeters.        
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Vijayajeyagopal. (2002)  conducted a study in the  by department of 
medicine, university of hull, U.K to assess the effect of dietary supplement with soya 
protein and isoflavones on insulin resistance, glycemic control, and cardiovascular 
risk markers in women aged 56-69with type 2 diabetes. A total of 32 women with 
diet-controlled type 2 diabetes completed a randomized, double blind, cross-over trial 
of dietary supplementation with phytoestrogens (soy protein 30 g/day, isoflavones 
132 mg/day) versus placebo (cellulose 30 g/day) for 12 weeks, separated by a 2-week 
washout period. The study results revealed that Compliance with the dietary 
supplementation was >90% for both treatment phases. When compared with the mean 
percentage change from baseline seen after 12 weeks of placebo, phytoestrogen 
supplementation demonstrated significantly lower mean values for fasting insulin 
(mean ± SD 8.09 ± 21.9%, P =0.006), insulin resistance (6.47 ± 27.7%, P = 0.003), 
HbA1c(0.64 ± 3.19%, P = 0.048), total cholesterol (4.07 ± 8.13%, P = 0.004), LDL 
cholesterol (7.09 ± 12.7%, P =0.001), cholesterol/HDL cholesterol ratio (3.89 ± 
11.7%, P = 0.015), and free thyroxin (2.50 ± 8.47%, P = 0.004).The study concluded 
that dietary supplementation with soya phytoestrogens favorably alters insulin 
resistance, glycemic control, and serum lipoproteins in postmenopausal women with 
type 2 diabetes, thereby improving their cardiovascular risk profile. 
 
Kawakami N (2001) conducted a clinical trials study  in Israel recruited145 
women ages 43-65 years to receive a soya rich diet or usual diet in a 2:1 ratio for 12 
week. The dietary intervention consisted of daily consumption of food known to 
contain high concentrations of soyaisoflavones and included tofu, soya drink, and 
miso plus flaxseed, substituting one-fourth of their caloric intake. Participants were 
evaluated with the Menopause Symptom Questionnaire, which includes questions on 
vasomotor and genitourinary symptoms.  Although 82% of the women reported eating 
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all or part of their assigned foods, the study does not report the actual amount 
consumed. Hot flashes and vaginal dryness scores were significantly reduced in both 
groups.  
 
3. LITERATURE RELATED TO EFFECT OF SOYA PROTEIN 
CONSUMPTION ON MENOPAUSAL SYMPTOMS 
Cheng G, Wilczek B et al (2011) conducted a  double-blind prospective study 
to evaluate the soya Isoflavone treatment for acute menopausal symptoms among 
sixty healthy postmenopausal women who were randomly assigned by computer into 
two groups to receive 60 mg soya isoflavones or placebo daily for 3 months. 
Climacteric symptoms were recorded before and after treatment, the study results 
revealed that hot flushes and night sweats were reduced by 57% and 43%, 
respectively. They concluded that soya isoflavones could be used to relieve acute 
menopausal symptoms. 
 
Kyoko Taku,  Melissa K. Melby et al (2010) conducted a clinical trials study  
to searched for relevant articles reporting double-blinded randomized controlled trials. 
This systematic review and meta-analysis, which evaluated the effects of isoflavones 
on the frequency, severity, or composite score (frequency ×severity) of hot flashes 
compared with placebo was conducted according to Cochrane Handbook guidelines.  
From 277 potentially relevant publications, 19 trials (reported in 20 articles) were 
included in the systematic review (13 included hot flash frequency; 10, severiety; and 
3, composite scores), and 17 trials were selected for meta-analyses to clarify the effect 
of soyabeanisoflavones on hot flash frequency (13 trials) and severity (9 trials). Meta 
analysis revealed that ingestion of soyaisoflavones (median, 54 mg; aglycone 
equivalents) for 6 weeks to 12 months significantly reduced the frequency (combined 
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fixed-effect and random effects model) of hot flashes by 20.6% (95% CI, j28.38 to 
j12.86; P G 0.00001) compared with placebo (heterogeneity P =0.0003, I2 = 67%; 
random effects model). Meta-analysis also revealed that isoflavones significantly 
reduced hot flash severity by 26.2% (95% CI: j42.23 to j10.15, P = 0.001) compared 
with placebo (heterogeneity, P G 0.00001, I2 = 86%; random effects. Isoflavone 
supplements providing more than 18.8 mg of genistein (the median for all studies) 
were more than twice as potent at reducing hot flash frequency than lower genistein 
supplements. Soyaisoflavone supplements, derived by extraction or chemical 
synthesis, are significantly more effective than placebo in reducing the frequency and 
severity of hot flashes. 
 
Cheduraui P, San Miguel et al (2010) conducteda study was  to evaluate the 
effect of soya-derived isoflavones over hot flushes, menopausal symptoms and mood 
in climacteric women with increased body mass index. Fifty symptomatic climacteric 
women aged 40 to 59 with increased BMI (≥ 25) were recruited to receive oral 100 
mg/day of soya derived isoflavones for 3 months. Hot flushes (frequency/intensity), 
menopausal symptoms (Menopause Rating Scale [MRS]) and mood (Hamilton 
Depressive Rating Scale [HDRS]) were evaluated at baseline and at 90 days. Study 
results After 3 months of soya isoflavone supplementation revealed that hot flushes 
significantly decreased in percentage, number and severity (100% to 31.1%; 3.9 ± 2.3 
to 0.4 ± 0.8 and 2.6 ± 0.9 to 0.4 ± 0.8, respectively, p < 0.001). MRS scores (total and 
for subscales) reflecting general menopausal symptoms also significantly decreased 
compared to baseline. Regarding mood, after three months total HDRS scores and the 
rate of women presenting depressed mood (scores ≥ 8) significantly decreased (16.3 ± 
5.4 to 6.9 ± 5.2 and  93.3% to 28.9%, respectively, p < 0.05).the study concluded that 
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In high risk climacteric population, soya derived isoflavone treatment improves mood 
as well as vasomotor and general menopausal symptoms. 
 
Duru shah, Sangeetha Agrawal, (2009) conducted a prospective randomized 
double blind study  to evaluate the effect of herbo mineral phytooestrogen formulation 
containing soya isoflavones in Indian women with signs and symptoms of menopause 
among 60 peri and post menopausal women in a public hospital. Women with 
symptoms related to menopause were randomized to either group A or group 
B(placebo) menopausal  symptoms were graded along a scale of Kupper man index at 
base line and changes were noted every 2 months and there after for a total of 6 
months. The group that received herbo mineral phytoestrogen showed 40% of 
improvement in psychological symptoms compared to placebo group. Improvement 
was noted in vasomotor symptoms, symptoms relating to sexual activity and urinary 
symptoms in group A Study concluded that herbo mineral phytoestrogen containing 
soya isoflavones is effective in management of symptoms in menopausal women. 
 
Song Y, Palik HY et al, (2008) conducted a longitudinal study  among 34 
women to investigate effect of soybean and isoflavone intake on bone mineral density 
(BMD) and its change among young Korean women over 2 years, The BMD was 
measured 3 times with 1-year intervals by dual x-ray absorptiometry at the lumbar 
spine and femur (neck, Ward's triangle [WT], and trochanter). Dietary intake was 
assessed up to 8 times by 24-hour recall with average 4-month interval. During, this 
study period that, BMD increased significantly for lumber spine and WT (2.5% and 
5.2%). The average daily intake of soya beans and isoflavones was 39 gm and 8 mg, 
respectively. Soyabean intake and total isoflavone intake had positive correlation on 
femoral neck (FN) and WT. By longitudinal mixed-model regression analysis, BMD 
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increased 0.26% per 1 mg of isoflavone intake per year in the FN and 0.31% for WT 
(P = .05 and .008). They  concluded that soybean and isoflavone intake have a 
positive effect on the change of BMD on the FN and WT among young Korean 
women. 
 
Basaria S, Wisniewelci, (2008) conducted a clinical trial study  to examine 
the safety and efficacy of an oral soya isoflavone extract on 177 postmenopausal 
women (mean age 55 years) experiencing five or more hot flashes per day. In this 
double-blind, placebo-controlled study the women were randomized to receive either 
soy isoflavone extract or placebo. Analysis after 12weeks showed a statistically 
significant reduction in average hot flash severity and frequency in the soya 
isoflavone group compared with the placebo group. In addition, decreases in the 
incidence and severity of hot flashes occurred as soon as 2 weeks in the soya group; 
whereas, the placebo group experienced no relief the first four weeks.  
 
Kakkar V (2007) conducted a double blind, placebo controlled trial study  to 
examine effects of 6 months supplementation of isoflavone rich soya protein on 
menopausal symptoms, lipid profiles and bone density in postmenopausal women. In 
this study 100 healthy postmenopausal women not taking Hormone replacement 
therapy, were randomly assigned to consume either 25gm soya protein containing 75 
mg isoflavones (study group) or 25 gm casein protein(control group) daily. Monthly 
assessment for acceptability & side effects, 3 monthly for menopausal symptoms 
(Kupperman Menopausal Index; KMI) and serum lipid-profile, 6 monthly for 
Follicular stimulating hormone, Estradiol levels, vaginal cytology, endometrial 
thickness and bone density were done. T-test, analysis of variance (ANOVA) and chi 
square tests were employed. In Result higher number of cases reported improvement 
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in hot-flashes,  joint-pains and vaginal-dryness on soya treatment (p<.05). Soy 
supplement was significantly superior to placebo in reducing KMI (p<.05). Soya 
group showed 7.7% decrease in total cholesterol and 14% decrease in LDL study 
concluded that 25gm soya supplement containing 75mg of isoflavones may be an 
effective alternative therapy for menopausal symptoms and may offer a benefit to 
cardiovascular-system by altering lipid-profile favorably. Supplementation of Soya 
protein isolate containing phyto estrogens significantly decreases total and low 
density cholesterol and improves menopausal symptoms as compared to placebo. 
 
De-Fu Ma, Li-Qiang Qin, Pei-Yu Wang, (2007) conducted a  randomized 
controlled trials related to the effects of soyaisoflavone intake on spine bone mineral 
density or spine bone mineral content and performed meta-analysis with Review 
Manager 4.2 software. Ten studies with a total of 608 women were selected for meta-
analysis. The spine bone mineral density in women who consumed isoflavones 
increased significantly by 20.6 mg/cm2 (95% confidence interval: 4.5–36.6 mg/cm2) 
in comparison to that in women who did not consume isoflavones. Isoflavone intake 
vs placebo intake increased spine bone mineral content by 0.93 g (95% confidence 
interval: −0.37 to 2.24 g) with borderline significance. Increases in the spine bone 
mineral density with isoflavone intake of more than 90 mg/day and with treatment 
lasting 6 months were 28.5 mg/cm2 (95% confidence interval: 8.4–48.6 mg/cm2) and 
27 mg/cm2 (95% confidence interval: 8.3–45.8 mg/cm2), respectively. Isoflavone 
intervention significantly attenuates bone loss of the spine in menopausal women. 
These favorable effects become more significant when more than 90 mg/day of 
isoflavones are consumed. And soy isoflavone consumption for 6 months can be 
enough to exert beneficial effects on bone in menopausal women. 
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Nahas EA, (2007) conducted a randomized, double-blind, placebo-controlled 
trial study  among 104 post menopausal women to assess the effect of dietary soya 
supplementation on hot flashes in postmenopausal women. 51 patients took 40 gm of 
isolated soya protein daily and 53 patients took 60 gm placebo (casein) daily. The 
study lasted for 12 weeks and using analysis of covariance baseline in mean number 
of moderate to severe hot flushes including night sweats during treatment was 
analyzed .The study results revealed that in women taking soya had a 26% reduction 
in mean number of hot flushes by week 3 and 33% reduction by week 4 and 45% 
reduction by week 12 versus 30% reduction obtained with placebo group. Study 
concluded that soya protein diet reduces hot flushes in menopausal women. 
 
AnjaJacohs (2007) conducted a randomized and placebo controlled studies  to 
assessed the efficacy of isoflavone supplements to reduce vasomotor symptoms in 
menopausal women by reviewing all published randomized controlled trials. 
Systematic literature searches were carried out in 70 databases. Randomized and 
placebo controlled studies were included if they investigated the treatment of 
isoflavone supplements derived from soya or red clover on vasomotor symptoms in 
peri- or postmenopausal women for at least 12 weeks. Data were analyzed concerning 
outcome and methodological quality of the study. Twenty-three trials met the 
inclusion criteria, there of 17 investigated soyaisoflavones and 6 red clover 
isoflavones. Without exception, selected trials examining the effect of red clover 
isoflavones were already assessed in several meta-analyses and were therefore 
excluded from this evaluation. As the soyaisoflavone studies were very heterogeneous 
concerning interventions and outcome measures, meta-analysis could not be 
performed and trials were systematically assessed in a structured approach. Included 
soyaisoflavone studies had numerous quality deficiencies and did not consistently 
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show a reduction of flushes after treatment with soyaisoflavones. Therefore, there is 
no conclusive evidence, but only some indication of a benefit of soy isoflavones on 
hot flush frequency or severity. 
 
Albertazzi et al(2006) conducted a randomized, double-blind, placebo-
controlled trial to assess the effect of daily dietary supplementation of soya protein 
isolate powder on hot flashes in postmenopausal women.  Age in the treatment group 
(n=51) was 48-61 years, while in the control group (n=53) it ranged from 45-62 years. 
The diets of the 104 women were supplemented with either 60 g soya powder (40 g 
isolated soya protein) or 60 g placebo (casein) daily for 12 weeks. By the end of the 
12th week, women taking the soya protein isolate had a 45-percent reduction in daily 
hot flashes compared to a 30-percent reduction obtained with  the placebo. 
 
Faure ED, Chantre.P (2006)  conducted a randomized, double-blind, 12-
week study in Australia with 58 postmenopausal women compared soy flour, which 
contains daidzin, to wheat flour, which contains lignans. Both groups experienced a 
significant reduction in the frequency of hot flashes – 40 percent in the soy flour 
group and 25 percent in the wheat flour group. The reduction from soy flour occurred 
six weeks earlier than that produced by wheat flour. Vaginal cell maturation, plasma 
lipids, and urinary calcium remained unchanged. 
 
Tomoko MD, somekawa et al, (2006) conducted a clinical trial study  in 478 
postmenopausal Japanese women. Estimated the daily intakes of isoflavones in the 
diets of 478 postmenopausal Japanese women who reported soy consumption. We 
recorded serum values of fasting total cholesterol, triglyceride, low-density 
lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoproteins. 
Bone mineral density was measured at the lumbar spine (L2–L4) by dual energy x-ray 
36 
 
absorptiometry. Women were assigned to two groups according to years since 
menopause (early and late postmenopausal groups), and each group was 
subcategorized into four groups according to dietary isoflavone intake. Relationships 
between isoflavone intake, menopausal symptoms, lipid profiles, and bone mineral 
density were examined in each group. The mean estimated intake of isoflavones 
among 478 women was 54.3 mg/day. With stepwise regression analysis we found that 
weight and years since menopause were significant independent predictors of bone 
mineral density. Bone mineral densities adjusted to years since menopause and weight 
were significantly different in the highest intake compared with lowest intake 
category (P < .001) within the early and late postmenopausal groups. In the early 
postmenopausal group, significant differences were found in palpitation and 
backaches between the high and low intake categories but were not significant in the 
late postmenopausal group. 
 
Elkind Hirsh K  (2005) conducted a randomized, double-blind, crossover 
study to evaluate  statistically significant decrease in hot flashes occurred in 51 
menopausal women consuming 20g  soya protein (containing 34 mg isoflavones) in 
single or split dosages compared to placebo (20g complex carbohydrates). After six 
weeks, a significant improvement was observed for the perceived severity of 
vasomotor symptoms (i.e., hot flashes) in both soya groups compared with placebo, 
although in the “twice daily” group the effect was greater. This suggests having 
consistent circulating levels of phytoestrogens may be more efficacious than a single 
higher dose. In addition, significant improvements in lipid and lipoprotein levels, as 
well as blood pressure, were noted in the treatment groups. 
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Van Patten CL, Olivotto IA, Chambers GK, et al. (2005) conducted 
arandomized, double-blind, placebo-controlled clinical trial with 123 postmenopausal 
breast cancer survivors with hot flashes. Breast cancer patients may experience 
worsening of vasomotor symptoms due to chemotherapy, tamoxifen, and/or 
discontinuation of HRT. This  study showed no significant difference in vasomotor 
symptoms between the soya (90 mg isoflavones daily) and placebo groups after 12 
weeks; however, both groups had a significant reduction in hot flashes (30-percent 
reduction with soya, 40-percent reduction with placebo.)  These results may not be 
extrapolated to a normal menopausal population due to the presence of 
chemotherapeutic medication. 
 
Murkieset al, (2005) conducted a clinical trialstudies were carried out on fifty 
eight postmenopausal women (age 54,  range 30-70 years) with at least 14 hot flushes 
per week, that their daily diet supplemented with soy flour (n = 28) compared with 
wheat flour (n = 30) over 12 weeks. Hot flushes significantly reduced in the groups 
with soy and wheat flour (40% and 25% reduction, respectively < 0.001 for both) with 
a significant rapid response in the soya flour group in 6 weeks (P < 0.001) that 
continued. Menopausal symptom score decreased significantly in both groups (P < 
0.05). 
 
Hazel A. Philp (2003) conducted  a randomized,double-blind, placebo-
controlled study among 75 postmenopausalwomen (55completed the study) 
experiencing at least seven hot flashes daily received either soya isoflavone extract 
(total of 70 mg genistin, the aglycone form of genistein, and daidzin, the aglycone 
form of daidzein, per day) or placebo. After 16 weeks, women taking the soya extract 
had a 61-percent reduction in daily hot flashes, versus a 21-percent reduction in the 
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placebo group. “Responders” (defined as patients whose hot flashes were reduced by 
at least 50 percent at the end of the treatment period) included 66 percent in the soya 
extract group and 34 percent in the placebo group. 
 
Upmalis et al(2003) examined the safety and efficacy of an oral soy 
isoflavone extract on 177 postmenopausal women (mean age 55 years) experiencing 
five or more hot flashes per day.  In this double-blind, placebo-controlled study the 
women were randomized to receive either soy isoflavone extract (total of 50 mg 
genistin and daidzin per day) or placebo. Analysis after 12 weeks showed a 
statistically significant reduction in average hot flash severity and frequency in the 
soy isoflavone group compared with the placebo group. In addition, decreases in the 
incidence and severity of hot flashes occurred as soon as two weeks in the soya group; 
whereas, the placebo group experienced no relief the first four weeks. Endometrial 
thickness, measured by ultrasound, did not change in either group. 
 
Kang HJ, Ansbacher R, (2002) conducted a study to  evaluated the effects of 
a 6 months soya rich diet on the vaginal epithelium of 187 menopausal women 39-60 
years old in Italian. Participants were randomized to soya, oestrogentheraphy or 
placebo. With the goal of providing 20-30mg/day of soya isoflavones, an intake 
comparable to the average consumption in Asian women, participants in the diet 
group were asked to add 1 soya food serving daily (soyamilk, miso, soup, tofu, etc) 
and a phytoestrogen food twice per week. The size of serving are not reported. Food 
diaries kept by the participants indicated a daily isoflavone consumption of 47mg, 
mostly from soya milk. Compliance in the study participants who remained in the 
study, assessed from pooled morning urine collected over 14 days, showed 
significantly higher urinary daidzein concentrations in the soya rich diet group. The 
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biggest increase in maturation value and karyopycnotic index was in the estrogen 
therapy group. These indices had a smaller but significant increase in the diet group 
and no change in the control. 
 
CONCEPTUAL FRAMEWORK: 
Conceptual framework deals with abstractions (concepts) that are assembled 
by virtue of their relevance to a common theme. Conceptualization is a process of 
forming ideas which is utilized and forms conceptual frame for development of  
research design. It helps the researcher by giving direction to go about entire research 
process. 
 
Conceptual frame work facilitates communication and provides for a 
systematic approach to nursing research, education, administration & practice. 
Conceptual framework is a brief explanation of theory  those portions of a theory 
which are to be tested in a study. It helps to organize the study and provide a context 
for the interpretation of the study results. 
 
KENNY’S OPEN SYSTEM MODEL: 
The study is based on J.W. KENNY’S OPEN SYSTEM MODEL (1991). All 
the living systems are open, in that there is continuous exchange of matter, energy and 
information. 
 
Open system has changing degree of interaction with the environment from 
which the System receives input and gives back out put in the form of matter, energy 
and information. For survival, all systems of nursing receive varying type and amount 
of matter, energy and information. 
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The main concept of open system model is: Input, Through Put, Output and 
Feedback. In open system theory input refers to matter, energy and information that 
are processed. After processing the input the system returns to output (matter, energy 
and information to the environment in an altered state). Feedback refers to 
environment response to the systems output used by the system in adjustment 
correction and accommodation to the interaction with the environment. 
 
The study is under taken to determine the effect of soya protein consumption 
on the menopausal symptoms. 
 
Pre test conducted to assess the symptoms of menopause like hot flushes, 
sleeplessness, night sweats etc. 
 
Input – Providing soya protein for reducing the menopausal symptoms. 
 
Through put – Through put is the process of soya protein consumption on 
menopausal symptoms among women. 
 
Post test – Again assessing the symptoms of menopause. Output – Refers to 
effect of soya protein consumption on menopausal symptom by post test. 
 
This module of Kenny’s Open System is best suited to this study 
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Fig: 1 Conceptual Framework based on J.W. Kenny’s Open System  Model (1991)
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CHAPTER - III 
RESEARCH METHODOLOGY 
METHODOLOGY 
Research methodology is an overall plan to conduct research study, which 
involves the description of  research approach, research design and variables under 
study, setting of the study, population, sample and sample size, sampling technique, 
Sampling criteria, development and description of the tool, content validity, 
reliability,Pilot study, data collection process and plan for analysis. 
 
 This chapter describes the methodology followed to assess the effectiveness of 
soya protein consumption on menopausal symptoms. It includes research approach, 
research design, and variables, setting of the study, population, inclusion criteria, 
sampling, development and description of tool, validity and reliability of tool, method 
of data collection and plan for data analysis. 
 
3.1 RESEARCH APPROACH  
 Research approach involves the description of plan to investigate the 
phenomenon under the study in a structured (Quantitative), unstructured (Qualitative) 
or a combination of two methods (Quantitative – Qualitative integrated approach). 
 
 Quantitative research approach was used in this study to evaluate the 
effectiveness of soya protein consumption on menopausal women. 
 
3.2 RESEARCH DESIGN 
 Research Design is a blue print that the researchers select to carry out their 
research study. The research design used in this study was Quasi-experimental–Non 
equivalent control group design. The study was conducted to evaluate the effectiveness of 
soya protein consumption on menopausal symptoms among women  inSamayanallur at 
Madurai. 
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GROUP PRETEST INTERVENTION POST TEST 
CONTROL 
GROUP 
O1 X O2 
EXPERIMENTAL 
GROUP 
O1  O2 
 
01= Pre test Assessment of the Menopausal symptoms in Control and  
Experimental group. 
X =  Consumption of Soya protein. 
02=  Post test Assessment of the Menopausal symptoms in Control and 
Experimental group. 
 
3.3 RESEARCH VARIABLES 
 Attributes or characteristics that can have more than one value are known as 
variables. 
 
VARIABLES IN THE STUDY: 
         Independent variable  - Soya protein 
 Dependent variable  - Menopausal symptoms 
         Demographic variable - Age, age of menarche, marital status, dietary pattern,  
religion, Educational status, occupation, income,  type of family, habits and parity. 
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3.4 SETTING OF THE STUDY 
 The setting of the study was selected on the basis of feasibility for conducting 
the study and availability of samples. The study was conducted  inSamayanallur at 
Madurai.     
 
3.5 POPULATION 
 The entire set of individuals (or women) having common characteristics 
-POLIT 
 
Target Population 
Population for the study comprises of menopausal women. 
 
Accessible Population  
Population for the study comprises of menopausal women living at 
Samayanallur, Madurai. 
 
3.6 SAMPLE:  
 A sample is the representative unit of a target population. 
Sample refers to the process of selecting a portion of the population which 
refers the entire population. The women were selected using purposive sampling 
technique. 
 
3.7 SAMPLE SIZE 
 The sample size of the study was 60.  
                                Control group               = 30 
                                Experimental group    = 30 
                                Total                             = 60 
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3.8 CRITERIA FOR SELECTION OF SAMPLES 
Inclusion criteria  
The study includes Women  
 who are having menopausal symptoms 
 between the ages 45-56years  
 who are willing to participate 
 who can understand and speak Tamil. 
 
Exclusion criteria 
 The study excluded women 
 who are not present at the time of data collection 
 who are on any hormonal treatment 
 
3.9 SAMPLING TECHNIQUE 
The samples were selected by Nonprobability –Purposive  sampling technique. 
 
3.10 METHOD OF SAMPLE SELECTION: 
The samples were selected those who met the inclusion criteria.  
 
3.11 RESEARCH TOOL  
The tool was developed after a wide literature review and by the guidance of 
the experts. The tool consists of two sections.  
Section A: Demographic variables  
Section B: Menopausal Rating Scale (Heinemann 2003) 
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3.12. Description of the tool 
 The tool consisted of two sections.  
Section – A 
Demographic variables: It consists of Age, Age of Menarche, Marital Status, 
Dietary Pattern, Religion, Educational status, Occupation, Family Monthly Income, 
Type of Family, Habits and Parity. 
 
Section – B 
Menopausal Rating Scale (Heinemann 2003) 
 It consists of 11 items to assess the menopausal problems of women.  
 It is a standardized, self-administered rating scale.  
 
Scoring method: 
S.No Menopausal Symptoms Score 
1              None 0 
2              Mild 1-11 
3               Moderate 12-22 
4               Severe 23-33 
5 Very severe 34-44 
 
3.13 TESTING OF THE TOOL: 
VALIDITY: 
 The content validity of the tool was obtained by giving the tool to 3 of the 
nursing experts in the field of Obstetrics and Gynecological Nursing, HOD (Head of 
the Department) and Professor of Obstetrics and Gynecological Department, 
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Professor of Obstetrics and Gynecology and Statistian. Experts’ suggestion were 
incorporated in the tool.   
 
RELIABILITY:  
The Menopause Rating Scale (MRS) is a well accepted instrument to measure 
the severity of menopausal symptoms. As yet however, investigations had not 
specifically been directed towards short-term test-retest reliability of the scale. The 
correlation coefficient (Pearson) of the sum-score of the two measurements was 
r=0.82. Hence the tool was considered highly reliable to precede the main study.  
 
3.14 EHICAL CONSIDERATION 
 The research proposal was approved by the experts of the Dissertation 
Committee in College of Nursing, Madurai Medical College, Madurai, and the same 
was approved by Institutional Review Board, Independent Ethical Committee of 
Government  Rajaji Hospital, and Madurai-20 for conducting the pilot study and main 
study. The formal permission was obtained from DDHS(Deputy Director of Health 
Service), Madurai. The committee suggested the researcher to continue study with 
slight modification. 
 
3.15 PILOT STUDY 
Research proposal was approved by the Institutional Ethical Committee Prior 
to the pilot study. A formal permission was obtained for the Head of the Department 
in Obstetrics and Gynecology and Pilot study was conducted from 01.8.2014 to 
07.8.2014 in Samayanallur, at Madurai. Formal permission was obtained from Block 
Medical Officer in Primary Health Centre, Samayanallur. Menopausal women were 
selected who fulfill the inclusion criteria of the study. Among 10 menopausal women, 
5 samples in experimental and 5 samples in control group were selected for the study. 
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Informed written consent was obtained from sample who was taking part in this study. 
The samples were selected by purposive sampling technique. 10 women aged between 
45-56 years, who satisfied the inclusion criteria were recruited and assigned 5 in 
experimental group and 5 in control group. Pretest data was collected by researcher 
using Heinemann menopausal rating scale for both the groups. Experimental group  
consumed60 gm cooked soya bean daily for one week. Control group  not consumed  
soya bean. Post test was conducted by researcher for both groups using the same 
menopausal rating scale on 1st day of second week. The study reveals that the study 
was feasible and practicable to conduct the main study.  
 
3.15 DATA COLLECTION PROCEDURE:  
The main study was conducted from 12.8.2014- 15.9.2014 at selected rural in 
Samayanallur. Formal permission was obtained from Deputy Director of Health 
Service, Vishwanathapuram and Medical Officer from Primary Health Center, 
Samayanallur. The purpose of the study was explained to the samples and 
confidentiality was maintained throughout the study. Informed written consent was 
obtained from sample who was taking part in this study. The samples were selected 
by purposive  sampling techniques. 30 women in experimental group and 30 women 
in control group. Pretest data collected by the researcher using Heinemann 
Menopausal rating scale for both groups. Experimental group  consumed 60 gm 
cooked soya bean daily for 4 weeks. Control group  without administration soya bean.  
Post test conducted by researcher for the both groups using the same Menopausal 
Rating Scale on first day of the 5th week. 
 
 
 
 
 
49 
 
3.16 PLANS FOR DATA ANALYSIS:  
Analysis and interpretation of data is the most important phase of research 
process, which involves the computation of certain measures along with searching for 
patterns of relationship that exist among data groups. Data were analyzed and 
interpreted in accordance with objectives. Data analysis is the process of organizing 
and synthesizing the data so as to answer the research questions and test hypothesis  
- SURESH. K.SHARMA  
 
Data were analyzed using descriptive and inferential statistics. Tests used in 
this study were frequency and percentage distribution, mean, standard deviation, chi- 
square test, and Paired‘t’ test. 
 
DESCRIPTIVE STATISTICS:  
Descriptive statistics is used to organize and summarize the data to draw 
meaningful interpretations.  
 Frequency, Percentage distribution was used to analyze the demographic 
variables of  womenin control and experimental group.  
 Mean and standard deviation were used to analyze the level of menopausal 
symptoms among  women in control and experimental  group.  
 
INFERENTIAL STATISTICS:  
 Paired‘t’ test was used to analyze the effectiveness of soya protein  
consumption on  women  in  control  and experimental group.  
 Chi- square test was used to find association between level of menopausal 
symptoms and demographic variables in control and experimental group.  
 
50 
 
3.17 PROTECTION OF HUMAN RIGHTS:  
The proposed study was conducted after getting approval from the dissertation 
committee of College of Nursing, Madurai medical College Madurai. In order to 
protect the human rights ethical committee approval was obtained on the month of 
February. In addition permission was obtained from Deputy Director of Health 
Services and Block Medical Officer in Primary Health Centre in Samayanallur. Both 
verbal and written consent was obtained from sample. The advantages of the study 
were explained to the samples. Samples were explained that confidentiality was 
maintained throughout the study. 
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Fig.2. SCHEMATIC REPRESENTATION OF THE STUDY 
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CHAPTER – IV 
DATA ANALYSIS AND INTERPRETATION 
 
 Thischapter deals with the analysis and interpretation of data collected from 
60 women with menopausal symptoms  inSamayanallur at Madurai. 
 
 Analysis and interpretation of data is the important step in research process. It 
involves the computation of the certain measures along with searching for patterns of 
relationship that exits among the data groups. 
 
 Analysis is the process of organizing and synthesizing the data so as to answer 
the research questions and test the hypothesis. 
- SURESH. K. SHARMA 
 
 The purpose of the analysis is to reduce the data to a manageable and 
interrupted form, so that research problem can be studied and tested. The data 
collected were analyzed according to the plan for data analysis and interpreted under 
the following objectives. 
 
The data were collected from 60 women with menopausal symptoms with the 
help of demographic variables Performa. Rating scale on menopausal symptoms 
before and after soya protein consumption to determine the effectiveness of soya 
protein. The data was analyzed based on objectives and hypothesis of the study. Data 
analysis was completed after transferring the collected data into a master coding 
sheet. The data as tabulated analyzed and interpreted using descriptive and inferential 
statistics. 
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ORGANIZATION OF DATA: 
SECTION A:  Distribution of demographic variables 
SECTION B: Description of level of Menopausal Symptoms for control and 
experimental group 
SECTION C:  Description the effectiveness of soya protein consumption 
control and experimental group 
SECTION D:  Comparison of level of Menopausal Symptoms between control 
and experimental group 
SECTION E: Association between levels of Menopausal Symptoms among control 
and experimental group 
 
SECTION A 
DISTRIBUTION OF DEMOGRAPHIC VARIABLES 
 
 This analysis has been done to find out the frequency and percentage 
distribution of demographic variables such as Age in years, Age of menarche, Marital 
status, Diet habit, Religion, Educational status, Occupation, Family monthly income, 
Type of family, Habits and Parity in control and experimental group. 
 
SECTION B 
DESCRIPTION  OF LEVEL OF MENOPAUSAL SYMPTOMS FOR 
CONTROL AND EXPERIMENTAL GROUP 
 
Levelsof menopausal symptoms among the menopausal women has been 
assessed  by Heinemann (2003) Menopausal Rating scale in five Stages (None, Mild, 
Moderate, Severe, Very severe) for control and experimental group. 
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SECTION C 
EVALUATE THE EFFECTIVENESS OF SOYA PROTEIN CONSUMPTION 
CONTROL AND EXPERIMENTAL GROUP 
 
Evaluate the effectiveness of the soya protein consumption among the women   
in control and experimental group. 
 
SECTION D 
COMPARISON OF LEVEL OF MENOPAUSAL SYMPTOMS BETWEEN 
CONTROL AND EXPERIMENTAL GROUP 
 Comparison of level of menopausal symptoms in experimental group and 
control group has been analyzed using mean score and its significance by statistical 
test. 
 
SECTION E 
ASSOCIATION BETWEEN LEVEL OF MENOPAUSAL SYMPTOMS 
AMONG CONTROL AND EXPERIMENTAL  GROUP WITH SELECTED 
DEMOGRAPHIC VARIABLES 
 
 Demographic variables of experimental and control group has been analyzed 
in association with level of menopausal symptoms using chi-square test. 
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SECTION A 
DISTRIBUTION OF DEMOGRAPHIC VARIABLES 
 
TABLE 1 : FREQUENCY AND PERCENTAGE DISTRIBUTION OF 
DEMOGRAPHIC VARIABLES OF MENOPAUSAL WOMEN  IN 
CONTROL AND EXPERIMENTAL GROUP 
n=60 
Demographic data 
Control group  Experimental group  
n % n % 
1.Age in years: 
a)45-48 yrs 
b)49-52 yrs 
c)53-55 yrs 
 
17 
9 
4 
 
56.7 
30 
13.3 
 
10 
4 
16 
 
33.3 
13.3 
53.3 
2.Age of menarche: 
a)Below 11 years 
b)11-15 years 
c)Above 15 years  
 
7 
22 
1 
 
23.3 
73.3 
3.3 
 
15 
14 
1 
 
50 
46.7 
3.3 
3.Marital status: 
a)Married 
b)Unmarried 
c)Widower  
 
23 
0 
7 
 
76.7 
0 
23.3 
 
19 
0 
11 
 
63.3 
0 
36.7 
4.Diet habit: 
a)Vegetarian  
b)Mixed   
 
8 
22 
 
26.7 
73.3 
 
8 
22 
 
26.7 
73.3 
5.Religion: 
a)Hindu 
b)Christian  
c)Muslim 
d)Others 
 
24 
6 
0 
0 
 
80 
20 
0 
0 
 
26 
4 
0 
0 
 
86.7 
13.3 
0 
0 
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6.Educational status: 
a)Non formal education 
b)School level  
c)College level 
 
24 
6 
0 
 
80 
20 
0 
 
25 
5 
0 
 
83.3 
16.7 
0 
7.Occupation: 
a)House wife 
b)Private  
c)Government 
 
24 
6 
0 
 
80 
20 
0 
 
25 
5 
0 
 
83.3 
16.7 
0 
8.Family monthly income: 
a)<Rs.5000 
b)Rs.5001-10000 
c)Above Rs.10000 
 
30 
0 
0 
 
100 
0 
0 
 
26 
4 
0 
 
86.7 
13.3 
0 
9.Type of family: 
a)Nuclear family 
b)Joint family 
c)Extended family 
 
23 
7 
0 
 
76.7 
23.3 
0 
 
19 
9 
2 
 
63.3 
30 
6.7 
10.Habits: 
a)Tobacco/betel chewing 
b)Increased intake of coffee/tea  
 
14 
16 
 
46.7 
53.3 
 
20 
10 
 
66.7 
33.3 
11.Parity : 
a)Nullipara 
b)Multipara  
c)Grand multipara 
 
2 
23 
5 
 
6.7 
76.7 
16.7 
 
2 
26 
2 
 
6.7 
86.7 
6.7 
 
 The above the table represents that age group of women among control group 
17 (56.7%) were in the age group of 45-48 years, 9 (30%) were in the age group of 
49-52 years, and  4 (13.3%) were in the age group of 53-55 years. In Experimental 
group 10 (33.3%) were in the age group of 45-48 years, 4 (13.3%) were in the age 
group of 49-52 years, and 16 (53.3%) were in the age group of 53-55 years.  
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 With the view of age of menarche, in the control group 7 (23.3%) of women 
attained menarche at the age of below 11 years, 22 (73.7%) attained menarche at the 
age of 11-15years, and 1 (3.3%) of women attained menarche at the age of above 15 
years. In Experimental group 15 (50%) of women attained menarche at the age of 
below 11 years, 14 (46.7%) attained menarche at the age of 11-15years, and 1 (3.3%) 
of women attained menarche at the age of above 15 years. 
 
In the view of marital status control group 23 (76.7%) women were married,  
7(23.3%) women were widower. In experimental group19 (63.3%) were married, 
1(36.7%) women were widower.  
 
 In the aspect of dietary pattern, in control group majority of the women in 22 
(73.3%) belongs to mixed diet and 8 (26.7%) belongs to vegetarian. In experimental 
group   majority of the women in 22 (73.3%) belongs to mixed diet and 8 (26.7%) 
belongs to vegetarian. 
 
 With regard to religion, in control group 24 (80%) belongs to Hindu religion, 
6(20%) belongs to Christian. In experimental group 24 (80%) belongs to Hindu 
religion, 6(20%) belongs to Christian.  
 
 In the view of educational status majority of the women in control group 24 
(80%) were illiterate, and 6 (20%) had school level education. In experimental group 
womenin 25 (83.3%) were illiterate and 5 (16.7%) had school level education. 
 
 In the view of occupational status majority of the women in control group 
24(80%) were house wife and 6 (20%) women were working as a private company. In 
experimental group 25 (83.3%) were house wife and 5 (16.7%) women were working 
as a private company. 
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 With regard of family monthly income majority of the women in control group 
30 (100%) get less than Rs.5000/-.  In experimental group majority of the women 26 
(86.7%) get less than Rs.5000/-.  And 4 (13.3%) women were get Rs 5001-10000/-. 
 
In the view of type of family, in control group 23 (76.7%) belongs to nuclear 
family, 7 (23.3%) belongs to joint family. In experimental group 19 (63.3%) belongs 
to nuclear family, 9 (30%) belongs to joint family, 2 (6.7%) belongs to extended 
family. 
 
 With the view of habits majority of the women in control group 16 (53.3%) 
were increased intake of coffee/tea, 14 (46.7%) were tobacco/betel chewing. In 
experimental group 20 (66.7%) were tobacco/betel chewing, 10 (33.3%) were 
increased intake of coffee/tea.  
 
 With the view of the parity majority of the women in control group 23 (76.7) 
were multipara, 5(16.7) were grandmultipara and 2 (6.7) were Nulllipara. Majority of 
the women in experimental group 26 (86.7) were multipara, 2 (6.7) were 
grandmultipara and 2 (6.7) were Nullipara. 
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Fig.2 Multiple bar diagram depictsdistribution of women according to their age. 
 
Majority of the women among control group 17 (56.7%) were in the age group 
of 45-48 years. In experimental group majority of the women 16 (53.3%) were in the 
age group of 53-55years. 
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Fig.3.Multiple cylinder diagram depicts distribution ofwomen according to their 
age a menarche. 
 
Majority of the women in control group 22 (73.3%)) attained menarche at the 
age of 11-15 years. Majority of the women  in experimental group 15 (50%) attained 
menarche at the age of below 11 years.  
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Fig.4 Multiple pyramid diagrams depicts distribution of women according to 
their Marital Status. 
 
Majority of the women among control group 23 (76.7%) women were 
married. Majority of the women in experimental group 19 (63.3%) were married.  
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Fig.5.Multiple pyramid diagram depicts distribution of women according to 
their diet habit. 
 
It reveals that the aspect of dietary pattern, majority of the women in control 
group 22 (73.3%) belongs to mixed diet. Majority of the women in experimental 
group 22(73.3%) belongs to mixed diet.  
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Fig.6. Multiple pyramid diagrams depicts distribution of women according to 
their religion. 
 
The aspect of Religion, a majority of the women in control group 24 (80%) 
belongs to Hindu religion. Majority of the womenin  experimental group 25(86.7%) 
belongs to Hindu religion. 
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Fig.7: Multiple cylinder diagrams depicts distribution ofwomen according to 
their educational status. 
 
Regarding educational status majority of the women in control group 24 
(80%) were illiterate. Majority of the women in experimental group 25 (83.3%) were 
school level education. 
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Fig.8.Multiple cylinder diagram depicts distribution of women according to their 
occupation. 
 
 
Regarding occupation majority of the women in control group 24 (80%) were 
house wife. Majority of the women in experimental group 25 (83.3%) were house 
wife.  
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Fig.9: Multiple cylinder diagrams depicts distribution ofwomen according to 
their family monthly income. 
 
It  reveals that majority of the women in control group 30 (100%) were get 
less than Rs.5000/-. Majority of the women in experimental group 26 (86.7%) were 
get less than Rs.5000 per month.  
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Fig.10: Multiple cylinder diagramsdepicts distribution ofwomen according to 
their type of family. 
 
Regarding type of family majority of the women in control group 23 (76.7%) 
belongs to nuclear family. Majority of the women in experimental group 19 (63.3%) 
were belongs to Nuclear family.  
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Fig.11: Multiple cylinder diagrams depicts distribution ofwomen according to 
their habits. 
 
Regarding habits most of the women among control group (46.7%) and 
experimental group (66.7%) were having betel chewing habits. Some of the women in 
control group (53.3%) and experimental group (33.3%) were having increased intake 
of coffee/tea habits. 
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Fig.12.Multiple cylinder diagram depicts distribution of women according to 
their parity 
 
Majority of the women among control group 23 (76.7%) and experimental group 26 
(86.7%) were Multipara women. 
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SECTION II 
DISTRIBUTION OF LEVEL OF MENOPAUSAL SYMPTOMS FOR  
CONTROL AND EXPERIMENTAL GROUP 
 
TABLE 2 : Frequency and percentage distribution the level of menopausal    
Symptoms among women in control and experimental group  
 n=60 
 
Level of menopausal 
symptoms 
 
Control 
group    
Experimental 
group  
Pre  test        Pre  test  
f % f % 
None - - - - 
Mild 3 10 2 6.7 
Moderate  27 90 28 93.3 
Severe  - - - - 
Very severe  - - - - 
Total  30 100 30 100 
 
This table reveals the majority of the  women among control group pretest 
score is 27 (90%) women were moderate menopausal symptoms and 3(10%) of 
women were mild menopausal symptoms.  Majority of the women  among in 
experimental group pretest score is 28(93.3%) women were moderate level of 
Menopausal symptoms and 2 (6.7%) women were mild level of Menopausal 
symptoms. 
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Fig: 13 Multiple bar diagram depicts distribution ofpretest level of Menopausal 
symptoms among women before intervention 
 
Majority of the women among control group 27 (90%) women were moderate 
level of menopausal symptoms. Majority of the women  among experimental group 
28 (93.7%) were moderate level of menopausal symptoms and 2 (6.3%) women were 
mild level of menopausal symptoms. 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
100
Control Pre test Experimental pre test
0 010 6.3
90 93.7
0 00 0
pe
rce
nta
ge 
Level of  Menopausal symptoms  in pre test  
None
Mild
Moderate
72 
 
SECTION III 
EVALUATE THE EFFECTIVENESS OF SOYA PROTEIN CONSUMPTION 
CONTROL AND EXPERIMENTAL GROUP 
 
TABLE 3: Frequency and percentage distribution to evaluate the effectiveness of 
soya protein consumption on the menopausal    Symptoms among women control 
and experimental group 
n=60 
Level of menopausal 
symptoms 
Control group   Experimental Group 
Post  test        Post  test  
f % f % 
None - - 2 6.7 
Mild 4 13.3 19 63.3 
Moderate  26 86.7 9 30 
Severe  - - - - 
Very severe  - - - - 
Total  30 100 30 100 
 
This table reveals the majority of the women  among control group post test 
score is 26(86.7%) of women were moderate level of menopausal  symptoms, 
4(13.3%) women were mild level of menopausal  symptoms.Majority of the women  
among in experimental group post test score is 19(63.3%) women were mild level of 
menopausal symptoms and 9 (30%) women were moderate level of menopausal  
symptoms and 2 (6.7%) women were none of the menopausal symptoms. 
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Fig: 14 Multiple bar diagram depicts distribution of post test level of 
Menopausal symptoms among after intervention 
 
After the intervention majority of the women among control group                       
26 (86.7%) women were moderate level of menopausal symptoms and 4 (13.3%) 
women were mild level of menopausal symptoms. Majority of the women  among 
experimental group 19 (63.3%) were mild level of menopausal symptoms and                       
9 (30%) women were Moderate  level of menopausal symptoms and 2 (6.7%)  women 
were none of the menopausal symptoms. 
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SECTION D 
COMPARISON OF LEVEL OF MENOPAUSAL SYMPTOMS WOMEN 
BETWEEN CONTROL AND EXPERIMENTAL GROUP 
 
TABLE NO 4 : Distribution of mean, SD and mean percentage of   control pre 
and post test to assess the effectiveness of soya protein consumption on the 
menopausal    Symptoms among women in Samayanallur at  Madurai. 
n=60 
 
 
  The above table portrays that in control group pre test mean score was  17.3, 
Standard Deviation 3.42, Mean % 39.3%. Where as in post test score Mean and 
Standard Deviation (M=17.07, SD=3.39, Mean % =38.7%). The mean difference was  
0.6. 
 
 
 
 
 
 
 
 
 
 
 
 
Level of 
menopausal 
symptoms 
Max 
score 
Control-pre test Control-post test 
Difference 
in mean % 
Mean SD Mean% Mean SD 
Mean
% 
44 17.3 3.42 39.3 17.07 3.39 38.7 0.6 
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TABLE NO 5: Distribution of mean, SD and mean percentage of experimental 
pre and post testto assess the effectiveness of soya protein consumption on the 
menopausal    Symptoms among women in Samayanallur at  Madurai 
n=60 
 
 
The above  table manifests that in Experimental group pretest value Mean and 
Standard Deviation (M=19.53, SD=3.67, Mean %=44%). Where as experimental post 
test mean score was (M=10.6, SD=3.70, Mean %=24%). The mean difference was 20. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level of 
menopausal 
symptoms 
 
 
Max 
Score 
 
Experimental –pretest 
scores 
Experimental –posttest 
scores 
 
 
Difference 
in mean % Mean SD Mean
% 
Mean SD Mean
% 
44 19.53 3.67 44 10.6 3.70 24 20 
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TABLE NO 6:  Distribution of mean, SD and mean percentage of   experimental   
post    and control post scores   to assess the effectiveness of soya protein 
consumption on the menopausal   Symptoms among women in Samayanallur at 
Madurai 
n=60 
 
 
The above  table shows that level of menopausal symptoms in control group 
post test Mean score was 17.07,  standard deviation  3.49, mean percentage 38.7. 
Where as in experimental group post test mean 10.6, standard deviation 3.70, mean 
percentage 24. Difference between the control group  and experimental group  mean 
was 14.7%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level of 
menopaus
al 
symptoms 
Max 
score 
Control-post   scores Experimental   post   
scores 
Difference 
in mean % 
Mean SD Mean
% 
Mean SD Mean
% 
44 17.07 3.39 38.7 10.6 3.70 24 14.7 
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TABLE NO 7: Paired t-test   for   control pre   and control post test to assess the 
effectiveness of soya protein consumption on the menopausal Symptoms among 
women in Samayanallur at  Madurai 
n=60 
Level of 
menopausal 
symptoms 
Control-Pre  scores Control-post   scores ‘t’-
value P-value Mean SD Mean SD 
17.3 3.42 17.07 3.39 1.91 0.06 
 
 
 The above table portrays that in control group pre test mean 17.3, SD=3.42.  In 
post test score  mean 17.07, standard deviation 3.39. The  ‘t’ value is 1.91 and the  P-
value is 0.06. The difference was not found to be statistically significant at 0.001 
levels.  
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TABLE NO 8: Paired t-test    for   experimental pre   and experimental post test 
to assess the effectiveness of soya protein consumption on the menopausal  
Symptoms among women Samayanallur at Madurai 
n=60 
 
Level of 
menopausal 
symptoms 
Experimental –pre 
scores 
Experimental -post  
scores 
‘t’-
value 
P-value 
Mean SD Mean SD 
19.53 3.67 10.6 3.70 21.52 0.000*** 
       (*** P<0.001   highly significant) 
 
        The table shows in Experimental group Mean and Standard Deviation of pre test  
score (M=19.53, SD=3.67) was higher than the post test value is (M=10.6, SD=3.70).  
‘t’ value is 21.52. P-value is 0.000. The difference was found to be statistically 
significant at 0.001 levels and can be attributed to effectiveness of soya protein 
consumption. Hypothesis is accepted. Hence it concludes the experimental group 
perceived less level of menopausal symptoms. Thus the soya protein consumption 
helps in reducing the menopausal symptoms. 
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TABLE 9 :Unpaired t-test for   control   post   and experimental post test to 
assess the effectiveness of soya protein consumption on the menopausal 
Symptoms among women Samayanallur at Madurai 
 
n=60 
 
Level of 
menopausal 
symptoms 
Control  -post  scores 
 
Experimental –post   
scores ‘t’-value P-value Mean  SD Mean  SD 
17.07 3.39 10.6 3.70 7.05 0.000*** 
    (*** P<0.001   highly significant) 
 
 
                The above  table identifying that experimental group mean  10.6,  and 
standard deviation 3.70. In control group post test mean  score was 17.07, and 
standard deviation 3.39. ‘t’ value is 7.05. P-value is 0.000.  The experimental group  
mean value is lower than the control group. The difference was found to be 
statistically significant at 0.001 levels and can be attributed to effectiveness of soya 
protein consumption.  
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SECTION E 
ASSOCIATION BETWEEN LEVELS OF MENOPAUSAL SYMPTOMS 
AMONG CONTROL AND  EXPERIMENTAL GROUP WITH 
DEMOGRAPHIC VARIABLES 
TABLE 10:  Association between   control   post   test regarding to assess the 
effectiveness of soya protein consumption on the menopausal    Symptoms 
among women  in Samayanallur at  Madurai with  selected demographic data. 
                                                                                                                    n=60 
     Demographic variables Mild  Moderate Χ2-value  
p-
value f % f % 
1.Age in years: 
a.45-48 yrs 
b.49-52 yrs 
c.53-55 yrs 
 
3 
0 
1 
 
10 
0 
3.3 
 
14 
9 
3 
 
46.7 
30 
10 
 
2.13 
(df=2) 
 
0.345 
 
2.Age of menarche: 
a.Below 11 years 
b.11-15 years 
c.Above 15 years  
 
2 
2 
0 
 
6.7 
6.7 
0 
 
5 
20 
1 
 
16.7 
66.7 
3.3 
 
1.903 
(df=2) 
 
 
0.386 
3.Marital status: 
a.Married 
b.Unmarried 
c.Widower 
 
3 
0 
1 
 
10 
0 
3.3 
 
20 
0 
6 
 
66.7 
0 
20 
 
0.007 
(df=1) 
 
 
0.933 
4.Diet habit: 
a.Vegetarian 
b.Mixed 
 
0 
4 
 
0 
13.3
 
8 
18 
 
26.7 
60 
 
1.68 
(df=1) 
 
0.195 
5.Religion: 
a.Hindu 
b.Christian 
c.Muslim 
d.Others 
. 
3 
1 
0 
 
 
10 
3.3 
0 
 
21 
5 
0 
 
70 
16.7 
0 
 
 
0.07 
(df=1) 
 
 
0.788 
6.Educational status: 
a.Non formal education 
b.School level  
c.College level 
 
2 
2 
0 
 
 
6.7 
6.7 
0 
 
22 
4 
0 
 
73.3 
13.3 
0 
 
2.59 
(df=1) 
 
0.107 
7.Occupation: 
a.House wife 
b.Private 
c.Government 
 
3 
1 
0 
 
10 
3.3 
0 
 
21 
5 
0 
 
70 
16.7 
0 
 
 
0.07 
(df=1) 
 
 
0.788 
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     Demographic variables Mild  Moderate Χ2-value  
p-
value f % f % 
8.Family monthly income: 
a.<Rs.5000 
b.Rs.5001-10000 
c.Above Rs.10000 
 
4 
0 
0 
 
13.3
0 
0 
 
26 
0 
0 
 
86.7 
0 
0 
 
 
0 
 
 
1 
9.Type of family: 
a.Nuclear family 
b.Joint family 
c.Extended family 
 
4 
0 
0 
 
13.3
0 
0 
 
19 
7 
0 
 
63.3 
23.3 
0 
 
1.41 
(df=1) 
 
0.236 
10.Habits: 
a.Tobacco/betal chewing 
b.Increased intake of 
coffee/tea  
 
2 
2 
 
6.7 
6.7 
 
12 
14 
 
40 
46.7 
 
0.02 
(df=1) 
 
0.886 
11.Parity : 
a.Nullipara 
b.Multipara 
c.Grand multipara 
 
0 
3 
1 
 
0 
10 
3.3 
 
2 
20 
4 
 
6.7 
66.7 
13.3 
 
0.502 
(df=4) 
 
0.778 
              
The above table represents that there was no significant between the selected 
Demographic Variables and post test score level of Menopausal symptoms in control 
group.  
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TABLE NO 11: Association between   experimental   post  test regardingto assess 
the effectiveness of soya protein consumption on the menopausal    Symptoms 
among women in Samayanallurat Madurai with selected demographic data. 
n=60 
     Demographic variables None  Mild  Moderate  Χ2-value  
p-
value f % f % f % 
1.Age in years: 
a)45-48 yrs 
b)49-52 yrs 
c)53-55 yrs 
 
0 
1 
1 
 
0 
3.3 
3.3 
 
6 
3 
10 
 
20 
10 
33.3
 
4 
0 
5 
 
13.3 
0 
16.7 
 
 
4.33 
(df=4) 
 
 
0.363 
2.Age of menarche: 
a)Below 11 years 
b)11-15 years 
c)Above 15 years  
 
1 
1 
0 
 
3.3 
3.3 
0 
 
8 
10 
1 
 
26.7 
33.3 
3.3 
 
6 
3 
0 
 
20 
10 
0 
 
 
1.808 
(df=4) 
 
0.771 
3.Marital status: 
a)Married 
b)Unmarried 
c)Widower  
 
1 
0 
1 
 
3.3 
0 
3.3 
 
11 
0 
8 
 
36.7 
0 
26.7
 
7 
0 
2 
 
23.3 
0 
6.7 
 
1.204 
(df=2) 
 
0.548 
4.Diet habit: 
a)Vegetarian  
b)Mixed   
 
0 
2 
 
0 
6.7 
 
3 
16 
 
10 
53.3
 
5 
4 
 
16.7 
13.3 
 
5.72 
(df=2) 
 
0.047*
5.Religion: 
a)Hindu 
b)Christian  
c)Muslim 
d)Others 
 
2 
0 
0 
0 
 
6.7 
0 
0 
0 
 
17 
2 
0 
0 
 
56.7 
6.7 
0 
0 
 
7 
2 
0 
0 
 
23.3 
6.7 
0 
0 
 
 
1.204 
(df=2) 
 
 
0.548 
6.Educational status: 
a)Non formal education 
b)School level  
c)College level 
 
2 
0 
0 
 
6.7 
0 
0 
 
16 
3 
0 
 
53.3 
10 
0 
 
7 
2 
0 
 
23.3 
6.7 
0 
 
0.61 
(df=1) 
 
 
0.737 
7.Occupation: 
a)House wife 
b)Private  
c)Government 
 
2 
0 
0 
 
6.7 
0 
0 
 
16 
3 
0 
 
53.3 
10 
0 
 
7 
2 
0 
 
23.3 
6.7 
0 
 
 
0.61 
(df=2) 
 
0.737 
8.Family monthly income: 
a)<Rs.5000 
b)Rs.5001-10000 
c)Above Rs.10000 
 
2 
0 
0 
 
6.7 
0 
0 
 
16 
3 
0 
 
53.3 
10 
0 
 
7 
2 
0 
 
23.3 
6.7 
0 
 
 
0.61 
(df=1) 
 
 
0.737 
 
9.Type of family: 
a)Nuclear family 
b)Joint family 
 
2 
0 
 
6.7 
0 
 
12 
5 
 
40 
16.7 
 
5 
4 
 
16.7 
13.3 
 
2.98 
(df=2) 
 
0.561 
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     Demographic variables None  Mild  Moderate  Χ2-value  
p-
value f % f % f % 
c)Extended family 0 0 2 6.7 0 0 
 
10.Habits: 
a)Tobacco/betal chewing 
b)Increased intake of 
coffee/tea  
 
 
1 
1 
 
3.3 
3.3 
 
13 
6 
 
43.3 
20 
 
6 
3 
 
20 
10 
 
0.28 
(df=1) 
 
0.871 
11.Parity : 
a)Nullipara 
b)Multipara  
c)Grand multipara 
 
0 
2 
0 
 
0 
6.7 
0 
 
2 
16 
1 
 
6.7 
53.3 
3.3 
 
0 
8 
1 
 
0 
26.7 
3.3 
 
 
1.67 
(df=4) 
 
 
0.796 
(*-P<0.05, significant and **-P<0.01 & ***-P<0.001, highly significant) 
 
The above table represents that there was significant association between the 
dietary pattern and post test level of Menopausal symptoms in Experimental group.  
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CHAPTER - V 
DISCUSSION 
 
This chapter deals with the detailed discussion of the results of the data 
interpreted through statistical analysis. The focus of the study was to assess the 
effectiveness of soya protein  consumption on the menopausal symptoms among 
women  in Samayanallur at  Madurai. The investigator adopted quasi experimental 
design. 60 menopausal women were selected from the age group of 45-56 years and 
having mild to moderate level of  Menopausal Symptoms. The level of Menopausal 
Symptoms experienced by the menopausal women was assessed by Heinemann 
Menopausal Rating Scale. The results are discussed according to the objectives and 
supporting studies.  
 
FINDINGS BASED ON DEMOGRAPHIC VARIABLES 
 Most of the women with Menopausal Symptoms in Control group were in the 
age group of 45-48years (56.7%), had age of menarche between 11-15years (73.3%), 
majority of them were married (76.7%), with mixed dietary pattern (73.3%), 
belonging to Hindu Religion (80%), were illiterate (80%), women were house wife 
(100%), with family income less than Rs.5000/- (100%), living in nuclear family 
(76.7%), had the habit of increased intake of coffee/Tea (53.3%). 
 
Most of the women with Menopausal Symptoms in Experimental group were 
in the age group of 53-55years (53.3%), had age of menarche below the 11years 
(50%), majority of them were married (63.3%), with mixed dietary pattern (73.3%), 
belonging to Hindu Religion (86.7%), were illiterate (83.3%), women were house 
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wife (83.3%), with family income less than Rs.5000/- (86.7%), living in nuclear 
family (63.3%), had the habit of increased intake of coffee/Tea (66.7%). 
 
With respect of age group of women among control group 17 (56.7%) were in 
the age group of 45-48 years, 9 (30%) were in the age group of 49-52 years, and 4 
(13.3%) were in the age group of 53-55 years. In Experimental group 10 (33.3%) 
were in the age group of 45-48 years, 4 (13.3%) were in the age group of 49-52 years, 
and 16 (53.3%) were in the age group of 53-55 years.  
 
 With the view of age of menarche, in the control group 7 (23.3%) of women 
attained menarche at the age of below 11 years, 22 (73.7%) attained menarche at the 
age of 11-15years, and 1 (3.3%) of women attained menarche at the age of above 15 
years. In Experimental group 15 (50%) of women attained menarche at the age of 
below 11 years, 14 (46.7%) attained menarche at the age of 11-15years, and 1 (3.3%) 
of women attained menarche at the age of above 15 years. 
 
In the view of marital status control group 23 (76.7%) women were married, 
7(23.3%) women were widower. In experimental group19 (63.3%) were married, 
11(36.7%) women were widower.  
 
 In the aspect of dietary pattern, in control group majority of the women in 22 
(73.3%) belongs to mixed diet and 8 (26.7%) belongs to vegetarian. In experimental 
group   majority of the women in 22 (73.3%) belongs to mixed diet and 8 (26.7%) 
belongs to vegetarian. 
 
 With regard to religion, in control group 24 (80%) belongs to Hindu religion, 
6(20%) belongs to Christian. In experimental group 24 (80%) belongs to Hindu 
religion, 6(20%) belongs to Christian.  
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 In the view of educational status majority of the women  in control group 24 
(80%) were illiterate, and 6 (20%) were school level education. In experimental group 
majority of the women in 25 (83.3%) were illiterate and 5 (16.7%) were school level 
education. 
 
 In the view of occupational status majority of the women in control group 
24(80%) were house wife and 6 (20%) women were working as a private company. In 
experimental group 25 (83.3%) were house wife and 5 (16.7%) women were working 
as a private company. 
 
 With regard of family monthly income majority of the women in control group 
30 (100%) get less than Rs.5000/-.  In experimental group majority of the women  26 
(86.7%) get less than Rs.5000/-.  And 4 (13.3%) women were get Rs 5001-10000/-. 
 
 In the view of type of family, in control group 23 (76.7%) belongs to nuclear 
family, 7 (23.3%) belongs to joint family. In experimental group 19 (63.3%) belongs 
to nuclear family, 9 (30%) belongs to joint family, 2 (6.7%) belongs to extended 
family. 
 
 With the view of habits majority of the women  in control group 16 (53.3%) 
were increased intake of coffee/tea, 14 (46.7%) were tobacco/betel chewing. In 
experimental group 20 (66.7%) were tobacco/betel chewing, 10 (33.3%) were 
increased intake of coffee/tea.  
 
 With the view of the parity majority of the women  in control group 23 (76.7) 
were multipara, 5(16.7) were grandmultipara and 2 (6.7) were Nulllipara.  Majority of 
the women in experimental group 26 (86.7) were multipara, 2 (6.7) were 
grandmultipara and 2 (6.7) were Nullipara. 
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FINDINGS BASED ON OBJECTIVES: 
The first objective was to assess the level menopausal symptoms among women 
both  Control and experimental group 
The level of menopausal symptoms among menopausal women in control 
group was assessed by Menopausal Rating  Scale with use of this technique the 
majority of the women 27 (90%) women were moderate level of Menopausal 
symptoms and 3 (10%) women were mild level of menopausal symptoms. Majority of 
the women  among in experimental group score is 28 (93.3%) women were moderate 
level of Menopausal symptoms and 2 (6.7%) women were mild level of Menopausal 
symptoms. 
 
This study can be compared to the study conducted by Chim H, Tan BH et 
al, (2005) among 495 Singaporean migrant women aged 40 to 60 to determine the 
prevalence of 17 menopausal symptoms. The mean age of participants was 49 years 
and the classical menopausal symptoms found were hot flushes (17.6%), vaginal 
dryness (20.7%) and night sweats (8.9%). The most prevalent symptom reported was 
low backache with aching muscle joints (51.4%). The most well-known effect of 
these is the "hot flash" or "hot flush", a sudden temporary increase in body 
temperature. These symptoms were reported due to hormonal changes underlying 
menopause, which are caused by aging, other health states, psychosocial factors and 
life style. 
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The second objective was to evaluate the effectiveness of soya bean consumption 
on menopausal symptoms among   women: 
After the intervention assessed the level of menopausal symptoms by using 
same menopausal rating scale. The majority of the women  among control group post 
test score is 26 (86.7%) of women were moderate level of Menopausal symptoms 4 
(13.3%) women were mild level Menopausal symptoms.Majority of the women  
among in experimental group 19 (63.3%) women were mild level of Menopausal 
symptoms and 9 (30%) women were moderate level of Menopausal symptoms and 2 
(6.7%) women were none of the Menopausal Symptoms. Mean and Standard 
Deviation of post test Menopausal symptoms score in Control group (M=17.7, 
SD=3.39) and Experimental group (M=10.60, SD=3.70).  ‘t’ value is 7.09. P-value is 
0.000. The difference was found to be statistically significant at 0.001 levels and can 
be attributed to effectiveness of soya bean consumption. The obtained mean post test 
of level of Menopausal symptoms score is 10.6 which were lower than the mean pre 
test level of Menopausal symptoms score is 19.53 in experimental group. The 
obtained ‘t’ value is 21.53 statistically significant by used the paired ‘t’ test. The 
reduction indicated that effectiveness of soya protein was given on Menopausal 
symptoms in experimental group. 
 
The present study is consistent with the study conducted by Muthamilselvi 
(2010) to evaluate the effectiveness of pretest and posttest level of knowledge on soya 
bean consumption in reducing Menopausal symptoms among women. A Menopausal 
rating scale was used in this study. Knowledge Pre test (M=13%, SD=1.94) and Post 
test (M=27.36%, SD=1.11) ‘t’-value is 46.22, P-value is 0.000. It was evident that 
overall knowledge in post test score was higher than the pretest score. Hence there 
was significant gain in level of knowledge. So that the intervention is effective.  
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Another study also consistent with the present study which was conducted by 
Silvina Levis (2010). A prospective clinical 6 week trial study was conducted in 
Australia enrolled 25 postmenopausal women who received a diet supplemented with 
soya flour, red clover sprouts or linseed each for 2 week in turn. Vaginal maturation 
value is increased after the 2 week soya rich diet (P<0.05) but not after red clover or 
linseed. 
 
Hence the Hypothesis1 (H1): There is a significant difference between the 
pretest and posttest level of Menopausal Symptoms among the menopausal women in 
Samayanallur at Madurai was accepted. 
 
The third objective was to associate the level of menopausal symptoms with 
selected demographic variables among women  incontrol and experimental 
group: 
Statistical association between the post test score and selected demographic 
variables were calculated in both group experimental and control group using Chi 
square test. In control group the results showed that there was no association found 
between the post test level of menopausal symptoms and selected demographic 
variables like age, age of menarche, marital status, dietary pattern,  religion, 
educational status, occupation, income,  type of family, habits and parity. In 
experimental group the calculated χ2 value 5.57 at   calculated P value is 0.01 which 
showed that there was significant association between post test score of level of 
menopausal symptoms and the dietary pattern of women. 
 
The present study is consistent with the study conducted by Shilpa D.V 
(2013) a clinical study was conducted in Kolar. The investigator used convenient 
sampling technique to select the samples from the total population.  Mean and 
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Standard deviation of post test menopausal symptom score were low in experimental 
group (M=12.950, SD=2.5849) compared to control group (M=17.550, SD= 3.5314). 
The difference was found to be statistically significant at 0.05 levels and can be 
attributed to effectiveness of soya bean consumption. There was significant 
association between the dietary pattern and post test menopausal symptoms in 
experimental group. 
 
Thus, Hypothesis 2 (H2): There is a significant association between level of 
menopausal symptoms with selected demographic variables (dietary pattern) 
was accepted. 
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CHAPTER – VI 
SUMMARY, CONCLUSION, IMPLICATIONS AND 
RECOMMENDATIONS 
 
 This chapter deals about summary of the study findings, conclusion, 
implications of the study in different areas of nursing like nursing education, nursing 
administration, nursing practice and nursing research and Recommendations. 
     “A study to assess the effectiveness of soya protein consumption on the 
menopausal    Symptoms among women in Samayanallur at Madurai.” 
 
6.1 SUMMARY OF THE STUDY: 
Menopause is a natural phenomenon, but then it causes many symptoms which 
deteriorates the health of the women and makes her in trouble for the increased 
chance of many complications. In the menopausal years, many women undergo 
noticeable and clinically observable physical changes resulting from hormonal 
fluctuations.  
 
 Signs and effects of the menopause transition can begin as early as age 40, 
although most women become aware of the transition in their mid to late 45s, often 
many years after the actual beginning of the perimenopausal window. The typical age 
range of menopause is between ages of 40 and 54 and the average for last period is 51 
years in western countries. In some developing countries, the median age for natural 
menopause is at 44 years. In India as per the 2007 reports, the mean age at menopause 
ranges from 40 to 50 years. 
 
Menopause doesn't creep up on women and hit them all of a sudden. There are 
Three distinct stages to menopause; Premenopause, Perimenopause and Post 
menopause. Premenopausal is the word used to describe the years leading up to last 
period, when the levels of reproductive hormones are already becoming lower. 
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Perimenopause is defined as the period immediately prior to menopause and the first 
year after menopause and Post menopause is the period after the final menstrual 
period. Climacteric is the phase of aging process during which a woman passes from 
the reproductive to the non-reproductive stage. This phase 4 covers 5-10 years on 
each side of menopause, premenopause and post menopause. (Alan H.DeCherney).    
 
Many pharmacological and nonpharmacological measures are being used by 
perimenopausal women for centuries to overcome these devastating symptoms. Soya 
protein one such agent used by perimenopausal women is (glycine max) a leguminous 
plant containing 40% protein, minerals (like calcium, iron, phosphorus, and zinc), 
vitamins (like B complex, vitamin E) and phytoestrogen and lecithin. FDA (Food and 
Drug Administration) has recommended adding 45 to 100 mg of soya diet in a day is 
beneficial to alleviate menopausal symptoms. 
 
Soya beans are very rich in nutritive components. Besides the very high 
protein content. It contains a lot of fiber and is rich in calcium, magnesium. 100g soya 
bean contains 36.5gm of protein and 200 mg of is flavones. 60gm soya bean contains 
21.9 gm. Daily recommended protein for women and is 46gm per day. According to 
an article published in a 2007 edition of the “Journal of the International Society of 
sports Nutrition” physically active women require protein 1.4 to 2.0 gram per 
kilogram of body weight. According to the Institute of medicine 0.8gram of protein 
per kilogram of body weight.  
 
 So the investigator conducted a study to assess the effectiveness of soya 
protein consumption on the menopausal Symptoms among women in Samayanallur at  
Madurai. 
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Objectives of the study were 
1. To assess the level menopausal symptoms among women in experimental 
and control group. 
2. To evaluate the effectiveness of soya protein consumption on menopausal 
symptoms among   women. 
3. To find the association between menopausal symptoms with selected 
demographic variables in experimental and control group. 
 
The following hypothesis were tested at 0.05% level 
H1:  There is a significant difference between the menopausal symptoms before 
and after soya protein consumption among women in control and experimental 
group. 
H2:  There is a significant association between menopausal symptoms with their 
selected demographic variable among control and experimental group.  
 
The setting of the study was conducted in Samayanallurat Madurai. The 
research approach used in the study was quantitative approach and the design was 
Quasi experimental Non randomized control group design. Non probability purposive 
sampling technique was used in this study. The sample size of the study was 60 
among that 30 were in experimental group, 30 were in control group. Heinemann 
Menopausal Rating scale was used to assess the level of menopausal symptoms. A 
wide review of related literature, professional experience and expert’s guidance 
provided strong foundation for the study. The content validity and reliability for the 
tool was obtained prior to the study. A pilot study was conducted prior to the main 
study and it showed that the study was feasible and practicable. The study is based on 
J.W.KENNY’S OPEN SYSTEM MODEL 1991. All the living systems are open, in 
that there is continuous exchange of matter, energy and information. Open system has 
changing degree of interaction with the environment from which the System receives 
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input and gives back out put in the form of matter, energy and information. For 
survival, all systems of nursing receive varying type and amount of matter, energy 
and information. The data collection was done for a period of four weeks from 
12.8.2014-15.9.2014.  Purposive sampling technique was used to selected the 
experimental group and control group. Assessed the level of menopausal symptoms 
for both control and experimental group.  Cooked soya bean 60 gram was given to the 
experimental group daily for four weeks. Control group without administration soya 
bean.  Post test was conducted on first day of fifth week using Heinemann Rating 
scale. The data were analyzed using descriptive and inferential statistics. 
 
MAJOR FINDINGS OF THE STUDY: 
Majority of the women among control group 17 (56.7%) were in the age group 
of 45-48 years. In experimental group majority of the women 16 (53.3%) were in the 
age group of 53-55years. 
 
Majority of the women in control group 22 (73.3%)) attained menarche at the 
age of 11-15 years. Whereas in experimental group majority of the women 15 (50%) 
attained menarche at the age of below 11 years.  
 
Majority of the women among control group 23 (76.7%) women were 
married. In experimental group majority of the women 19 (63.3%) were married.  
The aspect of dietary pattern, in control group a majority of the women 22 
(73.3%) belongs to mixed diet. In experimental group majority of the women 
22(73.3%) belongs to mixed diet.  
 
Regarding religion in control group majority of the women 24 (80%) belongs 
to Hindu religion. In experimental group majority of the women 25 (86.7%) belongs 
to Hindu Religion.  
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Regarding educational status in control group majority of the women 24 
(80%) was illiterate. In experimental group majority of the women 25 (83.3%) were 
school level education. 
 
Regarding occupation in control group majority of the women 24 (80%) was 
house wife. In experimental group majority of the women 25 (83.3%) were house 
wife.  
 
In control group majority of the women 30 (100%) were get less than 
Rs.5000/-. In experimental group majority of the women 26 (86.7%) were get less 
than Rs.5000 per month.  
 
Regarding type of family in control group majority of the women 23 (76.7%) 
belongs to nuclear family. In experimental group majority of the women 19 (63.3%) 
were belongs to Nuclear family.  
 
Regarding habits most of the women among control group (46.7%) and 
experimental group (66.7%) were betel chewing habits. Some of the women in control 
group (53.3%) and experimental group (33.3%) were increased intake of coffee/tea 
habits. 
 
The majority of the  women  among control group pretest score was 27 (90%) 
women were moderate level of menopausal symptoms and 3(10%) of women were 
mild menopausal symptoms.  Majority of the women  among in experimental group 
pretest score is 28(93.3%) women were moderate symptoms and 2 (6.7%) women 
were mild  symptoms. 
 
The majority of the women among control group post test score was 
26(86.7%) of women were moderate level of menopausal  symptoms, 4(13.3%) 
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women were mild level of menopausal  symptoms. Majority of the women among in 
experimental group post test score was 19(63.3%) women were mild level of 
menopausal symptoms and 9 (30%) women were moderate level of menopausal  
symptoms and 2(6.7%) women were none of the level of  menopausal symptoms. 
  
In control group pre test mean score was 17.3, Standard Deviation 3.42, Mean 
% 39.3%. Where as in post test score Mean and Standard Deviation (M=17.07, 
SD=3.39, Mean % =38.7%). The mean difference was 0.6. 
 
In Experimental group pretest value Mean and Standard Deviation (M=19.53, 
SD=3.67, Mean %=44%). Where as experimental post test mean score was (M=10.6, 
SD=3.70, Mean %=24%). The mean difference was 20. 
 
The level of menopausal symptoms in control group post test Mean score was 
17.07, standard deviation 3.49, mean percentage 38.7. Where as in experimental 
group post test mean 10.6, standard deviation 3.70, mean percentage 24. Difference 
between the control group and experimental group mean was 14.7%. 
 
In control group pre test mean 17.3, SD=3.42.  In post test score mean 17.07, 
standard deviation 3.39. The ‘t’ value is 1.91 and the  P-value is 0.06. The difference 
was not found to be statistically significant at 0.001 levels.  
 
 In Experimental group  Mean and Standard Deviation of pre test  score 
(M=19.53, SD=3.67) was higher than the post test value is (M=10.6, SD=3.70).  ‘t’ 
value is 21.52. P-value was 0.000. The difference was found to be statistically 
significant at 0.001 levels and can be attributed to effectiveness of soya protein 
consumption. Hypotheses was accepted. Hence it concludes the experimental group 
perceived less level of menopausal symptoms. Thus the soya protein consumption 
helps in reducing the menopausal symptoms. 
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In experimental group mean  10.6,  and standard deviation 3.70. In control 
group post test mean  score was 17.07, and standard deviation 3.39. ‘t’ value is 7.05. 
P-value is 0.000.  The experimental group  mean value is lower than the control 
group. The difference was found to be statistically significant at 0.001 levels and can 
be attributed to effectiveness of soya protein consumption.  
 
 Mean and Standard Deviation of pre test Menopausal symptoms score 
Experimental group (M=19.53, SD=3.67) and post test value is (M=10.6, SD=3.70).  
‘t’ value is 21.52. P-value is 0.000. The difference was found to be statistically 
significant at 0.001 levels and can be attributed to effectiveness of soya protein 
consumption. Hypothesis is accepted. Hence it concludes the experimental group 
perceived less level of menopausal symptoms. Thus the soya protein consumption 
helps in reducing the menopausal symptoms. 
 
 There is no significant between the selected Demographic Variables and post 
test score of Menopausal symptoms in control group.  
 
There is significant association between the dietary pattern and post test 
Menopausal symptoms in Experimental group.  
 
In experimental group there is significant association between the dietary 
pattern and post test Menopausal symptoms in Experimental group. Hence the 
Hypothesis is accepted. 
 
 Hence it concludes the experimental group perceived less level of menopausal 
symptoms. Thus the soya bean consumption helps in reducing the menopausal 
symptoms. 
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6.2 CONCLUSION: 
 According to the results of this study the menopausal women  who consuming 
of soya bean  60grams in 4 weeks  had significantly reduction in level of menopausal 
symptoms. So the soya protein  consumption in menopausal symptoms was one 
among the alternative form of medicine, very effective on reducing menopausal 
symptoms among the women.  Soya bean is a natural food. It contains phytoestrogen 
and Isofloven need for menopausal women. It is one of the best alternative method 
and treatment of menopausal symptoms. So the researcher concludes that soya protein 
consumption is an effective intervention to reduce menopausal symptoms. 
 
6.3 IMPLICATIONS OF THE STUDY: 
 The study has implications in nursing practice, nursing education, nursing 
research and nursing administration. 
 
NURSING PRACTICE: 
 The nurses should enlighten their knowledge on reducing menopausal 
symptoms by using non-pharmacological measures like alternative and 
complementary medicine. 
 Nurse can use evidenced based practice in improving and standard of care.  
 Nursing care is an art and science in providing quality care.  
 Health teaching is an integral part of nursing care. The nurse personnel need to 
educate women about menopausal symptoms and dietary modifications in 
managing symptoms with emerging health trends. 
 Health teaching can be imparted through mass media radio, television, etc.  
 As nurse counselor she can conduct individual and group counseling to 
educate women with menopausal symptoms regarding complementary and 
alternative therapies.  
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 Nurses must also know about soya protein supplements and its benefits and 
health promoting practices.  
 This helps clinical nurse to use and recommended soya protein to manage 
menopausal symptoms 
 
NURSING EDUCATION 
 With the emerging health care trends, nursing education must focus on non 
pharmacological therapies to enhance nursing care.  
 The nursing students should be taught about the importance of alternative 
measures to relieve menopausal symptoms such as Soya bean. 
 The nurse educator need to prepare the students to obtain skills in educating 
the mother about the importance of Soya protein  on menopausal symptoms 
and motivate the students in group discussions regarding menopause and 
importance of Soya protein. 
 Nurse educators should incorporate various alternative methods for reliving 
menopausal symptoms in their curriculum. 
 
NURSING ADMINISTRATION 
 With technological advances and the ever growing challenges of Health Care 
Needs, the administrators have a responsibility to provide nurses with 
substantive continuing education opportunities. 
 This will enable the nurses to update their knowledge, acquire special skills 
and demonstrate high quality care. 
 Nurse administrator should take initiative in organizing seminar, discussion 
and conference on Soya Protein and Menopausal symptoms.  
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 The nurse administrator should provide opportunities to the staff to attend 
training program on complementary and alternative therapy for reducing 
menopausal symptoms. 
 The nurse administrator can encourage staff nurses and student nurses and 
multiple health workers to involve in research activities of menopausal related 
problems. 
 
NURSING RESEARCH 
 There is need for extensive and intensive research in this area. More research 
Studies in India are needed to identify menopausal problems and importance 
ofAlternative therapies. 
 It opens a big avenue for research on natural remedies, consumption of Soya 
Protein  to decrease severity of menopausal symptom focus on quality, cost 
effective soas to generate more scientific data base on which new strategies for 
reducing theSymptoms can be developed. 
 
6.4 RECOMMENDATIONS: 
The study had drawn the following recommendation: 
 A similar study can be done with other type of soya products. 
 A similar study can be replicated with a larger sample 
 A similar study can be conducted in urban settings. 
 A Similar study can be done with the comparison of other alternative method. 
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menopausal symptoms among women between 45-56 years in  Samayanallur, Madurai” 
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thesis entitled “A study to assess the effectiveness of soya protein consumption on the 
menopausal symptoms among women between 45-56 years  in Samayanallur, Madurai” 
has been validated by me. 
 
 
 
 
 
 
 
  
 
 
 
 
 APPENDIX-IV 
INFORMED CONSENT FORM 
Xg;Gjy; mwpf;if 
 
ngah;:                            ehs;: 
          
 vdf;F ,e;j nrtpypa Ma;tpidg; gw;wpa KO tptuk; tpsf;fkhf 
vLj;Jiuf;fg;gl;lJ. ,e;j Ma;tpy; gq;Fnfhs;tjpy; cs;s ed;ikfs; kw;Wk; 
jPikfs; gw;wp KOikahf Ghpe;Jnfhz;Nld;. ,e;j Ma;tpy; jhdhf Kd; te;J 
gq;FngWfpNwd;. NkYk; vdf;F ,e;j Ma;tp;ypUe;J ve;j rkaj;jpYk; tpyfpf 
nfhs;s KO mDkjp toq;fg;gl;Ls;sJ. vd;Dila ngah; kw;Wk; 
milahsq;fs; ufrpakhf itj;Jf;nfhs;sg;gLk; vd;Wk; vdf;F 
cWjpaspf;fg;gl;Ls;sJ. 
 
 
 
ifnahg;gk 
 
 
 
DATA COLLECTION TOOL 
SECTION – A: DEMOGRAPHIC VARIABLE 
(Please put  mark in correct one) 
Sample No: 
1.Age in years 
      a. 45-48 years          
      b. 49- 52 years     
      c.53-55  years                                        
 
2. Age of Menarche 
       a. Below 11 years          
       b. 11-15 years 
       c. Above 15 years 
 
3. Marital status 
      a. Married          
      b. Unmarried 
      c. Widower  
 
4. Diet habit  
      a. Vegetarian 
      b.Mixed     
 
5. Religion 
       a. Hindu     
       b. Christian    
       c. Muslim     
       d. Others      
 
 
  
 
APPENDIX - V 
6. Educational status  
        a. Non formal education     
        b. School level     
        c. College level    
 
7. Occupation  
        a. House wife     
        b. Private   
        c.Government 
 
8. Family monthly income 
         a . < Rs 5000   
         b. Rs 5001 – 10000      
        c. Above Rs  10000     
 
9. Type of family   
         a. Nuclear family    
         b. Joint family    
         c. Extended family  
 
10. Habits 
   a. Tobacco/betel chewing 
   b. Increased intake of coffee/tea 
    
 
 
 
 
 
 
 
HEINEMANN MENOPAUSAL RATING SCALE (MRS) 
Symptoms 
None 
 
0 
Mild 
 
1 
Moderate 
 
2 
Severe 
 
3 
Very 
Severe 
4 
1. Hot flushes, sweating. (episodes of 
sweating). 
     
2. Heart discomfort (unusual Awareness of 
heart beat, heart skipping, heart racing, and 
tightness). 
     
3. Sleep problems (difficulty in falling 
asleep, difficulty in sleeping through, 
waking up early). 
     
4. Depressive mood (feeling down, sad, on 
the verge of tears, lack of drive, mood 
swings). 
     
5.Irritability (feeling nervous, inner tension, 
feeling aggressive). 
     
6. Anxiety (inner restlessness, feeling 
panicky). 
     
7. Physical and mental exhaustion (general 
decrease in concentration, forgetfulness ) 
     
8. Sexual problem (change in sexual desire, 
in sexual activity and satisfaction)  
     
9. Bladder problem (difficulty in urinating, 
increased need to urinate, bladder 
incontinence) 
     
10. Dryness of vagina (sensation of dryness 
or burning in the vagina, difficulty with 
sexual intercourse) 
     
11. Joint and muscular discomfort (pain in 
the joints, rheumatoid complaints) 
     
 
 
  
INTERPRETATION: 
 Menopausal symptoms   Score 
  None     0 
  Mild     1-11 
  Moderate    12-22 
  Severe     23-33 
  Very  severe    34-44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX – VI 
 
¾ýÉ¢¨Ä Å¢ÀÃ ÌÈ¢ôÒ 
 
ÀÌ¾¢-« 
 
¸£úì ¸ñ¼ÅüÈ¢ø º¡¢Â¡É ¾¸Å¨Ä ( ) ÌÈ¢ì¸×õ 
 
1.ÅÂÐ 
 
«) 45 Ó¾ø 48 ÅÂÐ Å¨Ã        
¬)49 Ó¾ø 52 ÅÂÐ Å¨Ã 
þ) 53 Ó¾ø 56 ÅÂÐ Å¨Ã 
 
2. ÀÕÅÁ¨¼ó¾ ÅÂÐ 
 
«) 11 ÅÂ¾¢üÌ ¸¢§Æ 
¬) 11 Ó¾ø 15 ÅÂÐ Å¨Ã 
þ) 15 ÅÂ¾¢üÌ §Áø 
 
 3. ¾¢ÕÁ½ ¿¢¨Ä 
 
«) ¾¢ÕÁ½Á¡ÉÅ÷ 
¬) ¾¢ÕÁ½Á¡¸¡¾Å÷ 
þ) Å¢¾¨Å 
 
4. ¯½× ÀÆì¸õ 
 
«.¨ºÅõ 
¬.«¨ºÅõ 
 
5. Á¾õ 
 
«.þóÐ 
¬.¸¢È¢Š¾Åõ 
þ. þŠÄ¡Á¢Â Á¾õ  
®)  À¢È Á¾ò¾¢É÷  
 
6. ¸øÅ¢ò ¾Ì¾¢ 
 «)ÀÊì¸Å¢ø¨Ä 
¬)ÀûÇ¢ÀÊôÒ 
þ)Àð¼ÀÊôÒ 
 
  
7. À½¢Â¢ý ¾ý¨Á 
«)Å£ðÎ ¦Å¨Ä ¦ºöÀÅ÷ 
¬)¾É¢Â¡÷ §Å¨Ä 
þ)«ÃÍ §Å¨Ä 
 
8. Á¡¾ ÅÕÁ¡Éõ 
 
«)å.5000-ìÌõ Ì¨ÃÅ¡¸ 
¬)å5001-å10,000 
þ)å10,000ìÌõ §Áø 
 
9. ÌÎõÀ Å¨¸ 
 
«)¾É¢ì ÌÎõÀõ 
¬)ÜðÎ ÌÎõÀõ 
þ)Å¢¡¢Å¡Éì ÌÎõÀõ 
 
10. ÀÆì¸ÅÆì¸í¸û 
  
«) Ò¨¸Â¢¨Ä ÁüÚõ ¦ÅüÈ¢¨Ä §À¡Î¾ø 
 ¬) ¸¡À¢ ÁüÚõ §¾É£÷ «¾¢¸ «Ç× «ÕóÐ¾ø 
 þ) ÁÐ «ÕóÐ¾ø 
 
11. ãurt¤â‹ v©Â¡if… 
m) FHªij…Æ‹ik… 
M) ïu©L  FHªij…fS¡F nk…š 
ï) IªJ FHªij…¡fS¡F nk…š 
 
 
 
 
 
 
 
 
Á¡¾Å¢¼¡ö Á¾¢ôÀ¢Î «Ç×§¸¡ø 
  
 
 
Å. 
±ñ 
 
 
«È¢ÌÈ¢¸û 
 
 
þø¨Ä
 
0 
 
 
º¢È¢¾û×
 
1 
 
 
Á¢¾Á¡É
 
2 
 
¸Î¨ÁÂ¡É 
 
3 
Á¢¸ì 
¸Î¨ÁÂ¡É
4 
1. ¯¼ø ¦ÅôÀ ¿¢¨Ä 
Á¡üÈõ, Å¢Â÷ò¾ø 
(«Êì¸Ê Å¢Â÷ò¾ø) 
 
 
 
    
2. þ¾Âì §¸¡Ç¡Ú¸û 
(þ¾ÂÐÊôÀ¢ø Á¡üÈõ, 
þ¾ÂôÀ¼À¼ôÒ 
þ¾Â þÚì¸õ) 
     
3. àì¸ò¾¢ø ²üÀÎõ 
À¢Ãîº¨É¸û  
(àíÌÅ¾¢ø º¢ÃÁõ, 
àíÌõ§À¡Ð 
º¢ÃÁôÀÎ¾ø, º£ì¸¢ÃÁ¡¸ 
±Øó¾¢Õò¾ø) 
     
4. ÁÉ «Øò¾õ 
(ÁÉî§º¡÷×, 
¸Å¨ÄôÀÎ¾ø, 
¸ñ½£÷ Å¢Î¾ø, 
Å¢ÕôÀÁ¢ý¨Á, ÁÉ 
¿¢¨Ä Á¡üÈõ) 
     
5. ±¡¢îºø (À¾ð¼ôÀÎ¾ø,  
¯û «Øò¾õ, 
§¸¡ÀôÀÎ¾ø)  
     
6. ÀÂõ (ÁÉ 
«¨Á¾¢Â¢ý¨Á, «¾¢¸ 
«Ç× ÀÂôÀÎ¾ø) 
     
7. ¯¼ø ÁüÚõ 
ÁÉî§º¡÷× (¦ºÂøÀ¡Î 
Ì¨È¾ø, ¿¢¨ÉÅ¡üÈø 
Ì¨È¾ø, Òò¾¢ìÜ÷¨Á 
Ì¨È¾ø, ÁÈ¾¢) 
     
8. À¡Ä¢Âø  À¢Ãîº¨É¸û  
(À¡Ä¢Âø  
Å¢ÕôÀÁ¢ý¨Á, À¡Ä¢Âø  
¿¼ÅÊì¨¸Â¢ø Á¡üÈõ, 
À¡Ä¢Âø  ¾¢Õô¾¢ 
Ì¨È×) 
     
9. º¢Ú ¿£÷ô¨À 
À¢Ãîº¨É¸û (º¢Ú ¿£÷ 
¸Æ¢ôÀ¾¢ø º¢ÃÁõ, 
«Êì¸Ê º¢Ú ¿£÷ 
¸Æ¢ò¾ø, º¢Ú ¿£÷ 
«¼ì¸ÓÊÂ¨Á) 
     
10. §Â¡É¢ ÅÈðº¢ (ÅÈðº¢ 
¯½÷×, ±¡¢îºø, 
¯¼ÖÈÅ¢ø º¢ÃÁõ) 
     
11. ãðÎ ÁüÚõ ¾¨º 
À¢Ãîº¨É¸û 
(ãðÎ¸Ç¢ø ÅÄ¢, ãðÎ 
À¢Ãîº¨É¸û) 
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APPENDIX-IX 
 
THE INVESTIGATOR DISTRIBUTE THE SOYA BEAN 
 
